| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin filament binding | TPM4 MYH3 MYH10 MYH13 CAPZA1 MYO18A MACF1 MYH15 PLEC NEXN FMNL1 | 2.00e-06 | 227 | 158 | 11 | GO:0051015 |
| GeneOntologyMolecularFunction | calmodulin binding | UNC13B MYH3 MYH10 MYH13 CALD1 ADCY1 DDX5 KCNH1 SCN2A IQCB1 MYH15 | 2.27e-06 | 230 | 158 | 11 | GO:0005516 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TPM4 TPR MYH3 MYH10 MYH13 CALD1 ANK3 FNTA CAPZA1 MYO18A RELA CCDC88A USH1G SYNE2 IRAG2 MACF1 MYH15 PLEC ARHGEF2 TNNT1 NEXN TOR1AIP1 FMNL1 MX2 | 5.86e-06 | 1099 | 158 | 24 | GO:0008092 |
| GeneOntologyMolecularFunction | chromatin binding | TPR TCF7L2 POLR2A NSD1 RELA MORC2 FANCM TTF1 DDX5 MEOX1 SAFB BRD4 ATAD2B AUTS2 TAF1 RERE NKAPL NIPBL DNMT1 | 6.34e-06 | 739 | 158 | 19 | GO:0003682 |
| GeneOntologyMolecularFunction | actin binding | TPM4 MYH3 MYH10 MYH13 CALD1 CAPZA1 MYO18A CCDC88A SYNE2 MACF1 MYH15 PLEC NEXN FMNL1 | 2.84e-05 | 479 | 158 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | UIMC1 TCF7L2 TRIB2 NSD1 RELA AIP TRIP12 DDX5 PTPN2 LATS1 TAF1 SPEN DNMT1 | 2.85e-05 | 417 | 158 | 13 | GO:0061629 |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 5.10e-05 | 83 | 158 | 6 | GO:1990841 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 1.24e-04 | 187 | 158 | 8 | GO:0016922 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | UIMC1 TCF7L2 TRIB2 TCF12 NSD1 RELA AIP TRIP12 DDX5 PTPN2 LATS1 TAF1 SPEN DNMT1 | 2.23e-04 | 582 | 158 | 14 | GO:0140297 |
| GeneOntologyMolecularFunction | microfilament motor activity | 2.26e-04 | 38 | 158 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 2.40e-04 | 206 | 158 | 8 | GO:0140030 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.55e-04 | 118 | 158 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MRE11 DDX19A MYH3 MYH10 MYH13 MYO18A UBA2 MORC2 FANCM DDX5 ATAD2B MACF1 MYH15 DNAH11 | 3.83e-04 | 614 | 158 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | transcription corepressor activity | 4.88e-04 | 229 | 158 | 8 | GO:0003714 | |
| GeneOntologyMolecularFunction | transcription factor binding | UIMC1 TCF7L2 TRIB2 TCF12 NSD1 UBA2 RELA AIP TRIP12 DDX5 PTPN2 LATS1 TAF1 SPEN DNMT1 | 9.59e-04 | 753 | 158 | 15 | GO:0008134 |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 1.69e-03 | 30 | 158 | 3 | GO:0070577 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 1.86e-03 | 31 | 158 | 3 | GO:0140033 | |
| GeneOntologyBiologicalProcess | cell cycle process | TPR UIMC1 MRE11 ZWILCH MYH10 ANK3 SDCCAG8 SLFN12 CENPU TRIM39 SNX33 BCL7A MORC2 FANCM PRPF40A ESCO1 CEP63 NEK1 LATS1 BRD4 MKI67 CEP131 PSME3 TAF1 PLEC ARHGEF2 IK NIPBL | 4.48e-06 | 1441 | 158 | 28 | GO:0022402 |
| GeneOntologyBiologicalProcess | actin filament-based process | TPM4 MYH3 MYH10 CDC42BPA CALD1 DSP PPFIA1 CAPZA1 MYO18A ARHGAP6 CCDC88A LATS1 KCNH2 SCN2A SYNE2 AUTS2 MYH16 PLEC ARHGEF2 TNNT1 FMNL1 | 6.65e-06 | 912 | 158 | 21 | GO:0030029 |
| GeneOntologyBiologicalProcess | chromatin organization | SART3 TPR UIMC1 MRE11 NSD1 RNF40 RELA BCL7A MORC2 TTF1 TRIP12 ZBTB1 SAFB BRD4 ATAD2B MKI67 TAF1 RERE NIPBL DNMT1 | 1.76e-05 | 896 | 158 | 20 | GO:0006325 |
| GeneOntologyBiologicalProcess | cell cycle checkpoint signaling | 4.63e-05 | 217 | 158 | 9 | GO:0000075 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | SART3 TPR UIMC1 MRE11 NSD1 RNF40 RELA BCL7A MORC2 TTF1 TRIP12 ZBTB1 SAFB BRD4 ATAD2B MKI67 TAF1 RERE NIPBL DNMT1 | 8.08e-05 | 999 | 158 | 20 | GO:0071824 |
| GeneOntologyBiologicalProcess | regulation of cell cycle | CDK8 TPR UIMC1 MRE11 ZWILCH FNTA GRK5 SLFN12 TRIM39 RNF40 BCL7A MBIP PRPF40A CEP63 NEK1 LATS1 BRD4 MKI67 CEP131 PSME3 TAF1 IK MX2 | 8.83e-05 | 1256 | 158 | 23 | GO:0051726 |
| GeneOntologyBiologicalProcess | actomyosin structure organization | MYH3 MYH10 CDC42BPA PPFIA1 MYO18A ARHGAP6 CCDC88A PLEC TNNT1 | 9.73e-05 | 239 | 158 | 9 | GO:0031032 |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle phase transition | 1.47e-04 | 311 | 158 | 10 | GO:1901988 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | TPM4 MYH3 MYH10 CDC42BPA CALD1 PPFIA1 CAPZA1 MYO18A ARHGAP6 CCDC88A LATS1 AUTS2 MYH16 PLEC ARHGEF2 TNNT1 FMNL1 | 1.48e-04 | 803 | 158 | 17 | GO:0030036 |
| GeneOntologyBiologicalProcess | maintenance of protein location in membrane | 1.74e-04 | 3 | 158 | 2 | GO:0072658 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in plasma membrane | 1.74e-04 | 3 | 158 | 2 | GO:0072660 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle phase transition | TPR UIMC1 MRE11 ZWILCH SLFN12 TRIM39 BCL7A CEP63 NEK1 BRD4 PSME3 TAF1 IK | 1.77e-04 | 516 | 158 | 13 | GO:1901987 |
| GeneOntologyBiologicalProcess | chromatin remodeling | SART3 TPR UIMC1 MRE11 NSD1 BCL7A MORC2 TTF1 TRIP12 ZBTB1 BRD4 ATAD2B TAF1 RERE NIPBL DNMT1 | 1.87e-04 | 741 | 158 | 16 | GO:0006338 |
| GeneOntologyBiologicalProcess | epithelial cilium movement involved in determination of left/right asymmetry | 1.88e-04 | 15 | 158 | 3 | GO:0060287 | |
| GeneOntologyBiologicalProcess | chromosome segregation | TPR MRE11 ZWILCH CENPU BCL7A MORC2 CEP63 LATS1 BRD4 MKI67 IK NIPBL | 2.53e-04 | 465 | 158 | 12 | GO:0007059 |
| GeneOntologyBiologicalProcess | face morphogenesis | 2.69e-04 | 41 | 158 | 4 | GO:0060325 | |
| GeneOntologyCellularComponent | actin cytoskeleton | TPM4 MYH3 MYH10 CDC42BPA MYH13 CALD1 CAPZA1 MYO18A TAX1BP3 ARHGAP6 USH1G AUTS2 MACF1 MYH15 MYH16 PEAK1 ARHGEF2 TNNT1 NEXN | 1.16e-07 | 576 | 162 | 19 | GO:0015629 |
| GeneOntologyCellularComponent | myosin filament | 1.23e-06 | 25 | 162 | 5 | GO:0032982 | |
| GeneOntologyCellularComponent | nuclear body | SART3 UIMC1 MRE11 SRRM1 TCF7L2 TCF12 GRK5 GON4L SRSF11 TRIP12 ZBTB1 PRPF40A SF1 DDX5 RBM25 RBM27 USH1G MKI67 SAFB2 RERE IK MAPK7 | 1.94e-06 | 903 | 162 | 22 | GO:0016604 |
| GeneOntologyCellularComponent | myosin II complex | 2.24e-06 | 28 | 162 | 5 | GO:0016460 | |
| GeneOntologyCellularComponent | myosin complex | 6.33e-06 | 59 | 162 | 6 | GO:0016459 | |
| GeneOntologyCellularComponent | supramolecular fiber | TPM4 MYH3 ZWILCH MYH10 MYH13 CALD1 ANK3 DSP MYO18A RIBC1 EFHB CEP170 ARHGAP6 RADIL SYNE2 CFAP45 MACF1 MYH15 PLEC ARHGEF2 TNNT1 NEXN MX2 DNAH11 | 1.37e-05 | 1179 | 162 | 24 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | TPM4 MYH3 ZWILCH MYH10 MYH13 CALD1 ANK3 DSP MYO18A RIBC1 EFHB CEP170 ARHGAP6 RADIL SYNE2 CFAP45 MACF1 MYH15 PLEC ARHGEF2 TNNT1 NEXN MX2 DNAH11 | 1.53e-05 | 1187 | 162 | 24 | GO:0099081 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | CDK8 SART3 TPR UIMC1 MRE11 SRRM1 TCF7L2 TCF12 POLR2A UBQLN4 NSD1 UBA2 GON4L RELA BCL7A FANCM PRPF40A SF1 DDX5 BRD4 SYNE2 TAF1 RERE IK NIPBL MX2 | 2.13e-05 | 1377 | 162 | 26 | GO:0140513 |
| GeneOntologyCellularComponent | myofibril | 5.55e-05 | 273 | 162 | 10 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 9.16e-05 | 290 | 162 | 10 | GO:0043292 | |
| GeneOntologyCellularComponent | nuclear speck | SART3 SRRM1 TCF12 GRK5 SRSF11 TRIP12 PRPF40A DDX5 RBM25 RBM27 USH1G IK | 1.41e-04 | 431 | 162 | 12 | GO:0016607 |
| GeneOntologyCellularComponent | centriole | 3.95e-04 | 172 | 162 | 7 | GO:0005814 | |
| GeneOntologyCellularComponent | ciliary transition zone | 4.19e-04 | 81 | 162 | 5 | GO:0035869 | |
| GeneOntologyCellularComponent | centriolar satellite | 4.92e-04 | 128 | 162 | 6 | GO:0034451 | |
| GeneOntologyCellularComponent | 9+0 motile cilium | 8.77e-04 | 6 | 162 | 2 | GO:0097728 | |
| GeneOntologyCellularComponent | spindle | TPR ZWILCH MYH10 MBIP CEP63 CEP170 LATS1 IQCB1 IRAG2 ARHGEF2 IK | 1.15e-03 | 471 | 162 | 11 | GO:0005819 |
| GeneOntologyCellularComponent | fibrillar center | 1.38e-03 | 156 | 162 | 6 | GO:0001650 | |
| GeneOntologyCellularComponent | nuclear envelope | TPR GRK5 ZBTB1 GTF3C3 UBXN4 KCNH1 SYNE2 IRAG2 CEP131 PRKG2 TOR1AIP1 MX2 | 1.44e-03 | 560 | 162 | 12 | GO:0005635 |
| GeneOntologyCellularComponent | nuclear membrane | 1.64e-03 | 349 | 162 | 9 | GO:0031965 | |
| GeneOntologyCellularComponent | actomyosin | 2.19e-03 | 117 | 162 | 5 | GO:0042641 | |
| Domain | Myosin_tail_1 | 3.39e-07 | 18 | 160 | 5 | PF01576 | |
| Domain | Myosin_tail | 3.39e-07 | 18 | 160 | 5 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 4.57e-07 | 19 | 160 | 5 | IPR027401 | |
| Domain | - | 4.57e-07 | 19 | 160 | 5 | 4.10.270.10 | |
| Domain | IQ | 1.34e-06 | 93 | 160 | 8 | PS50096 | |
| Domain | IQ | 6.07e-06 | 81 | 160 | 7 | SM00015 | |
| Domain | PWI | 6.09e-06 | 5 | 160 | 3 | PF01480 | |
| Domain | - | 6.09e-06 | 5 | 160 | 3 | 1.20.1390.10 | |
| Domain | PWI_dom | 6.09e-06 | 5 | 160 | 3 | IPR002483 | |
| Domain | Myosin_N | 6.58e-06 | 15 | 160 | 4 | PF02736 | |
| Domain | Myosin_N | 6.58e-06 | 15 | 160 | 4 | IPR004009 | |
| Domain | - | 1.21e-05 | 6 | 160 | 3 | 3.90.1290.10 | |
| Domain | IQ_motif_EF-hand-BS | 1.22e-05 | 90 | 160 | 7 | IPR000048 | |
| Domain | Myosin_head_motor_dom | 1.73e-05 | 38 | 160 | 5 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.73e-05 | 38 | 160 | 5 | PS51456 | |
| Domain | Myosin_head | 1.73e-05 | 38 | 160 | 5 | PF00063 | |
| Domain | MYSc | 1.73e-05 | 38 | 160 | 5 | SM00242 | |
| Domain | Plectin | 2.11e-05 | 7 | 160 | 3 | PF00681 | |
| Domain | Plectin_repeat | 2.11e-05 | 7 | 160 | 3 | IPR001101 | |
| Domain | PLEC | 2.11e-05 | 7 | 160 | 3 | SM00250 | |
| Domain | IQ | 3.25e-05 | 71 | 160 | 6 | PF00612 | |
| Domain | Spectrin_repeat | 1.04e-04 | 29 | 160 | 4 | IPR002017 | |
| Domain | SPEC | 1.55e-04 | 32 | 160 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.55e-04 | 32 | 160 | 4 | IPR018159 | |
| Domain | PWI | 2.18e-04 | 3 | 160 | 2 | SM00311 | |
| Domain | PWI | 2.18e-04 | 3 | 160 | 2 | PS51025 | |
| Domain | Bromodomain | 3.05e-04 | 38 | 160 | 4 | PF00439 | |
| Domain | BROMODOMAIN_2 | 4.10e-04 | 41 | 160 | 4 | PS50014 | |
| Domain | Bromodomain | 4.51e-04 | 42 | 160 | 4 | IPR001487 | |
| Domain | BROMO | 4.51e-04 | 42 | 160 | 4 | SM00297 | |
| Domain | - | 4.51e-04 | 42 | 160 | 4 | 1.20.920.10 | |
| Domain | ACTININ_2 | 9.63e-04 | 23 | 160 | 3 | PS00020 | |
| Domain | ACTININ_1 | 9.63e-04 | 23 | 160 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 9.63e-04 | 23 | 160 | 3 | IPR001589 | |
| Domain | Myb-like_dom | 1.07e-03 | 6 | 160 | 2 | IPR017877 | |
| Domain | AGC-kinase_C | 1.35e-03 | 56 | 160 | 4 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 1.35e-03 | 56 | 160 | 4 | PS51285 | |
| Domain | S_TK_X | 1.35e-03 | 56 | 160 | 4 | SM00133 | |
| Domain | Bromodomain_CS | 1.39e-03 | 26 | 160 | 3 | IPR018359 | |
| Domain | RRM_1 | 2.13e-03 | 208 | 160 | 7 | PF00076 | |
| Domain | FHA_DOMAIN | 2.33e-03 | 31 | 160 | 3 | PS50006 | |
| Domain | CNMP_BINDING_1 | 2.55e-03 | 32 | 160 | 3 | PS00888 | |
| Domain | CNMP_BINDING_2 | 2.55e-03 | 32 | 160 | 3 | PS00889 | |
| Domain | RRM | 2.70e-03 | 217 | 160 | 7 | SM00360 | |
| Domain | cNMP | 3.04e-03 | 34 | 160 | 3 | SM00100 | |
| Domain | cNMP_binding | 3.04e-03 | 34 | 160 | 3 | PF00027 | |
| Domain | MIF4G | 3.14e-03 | 10 | 160 | 2 | SM00543 | |
| Domain | MIF4G | 3.14e-03 | 10 | 160 | 2 | PF02854 | |
| Domain | MIF4G-like_typ-3 | 3.14e-03 | 10 | 160 | 2 | IPR003890 | |
| Domain | PAS_9 | 3.14e-03 | 10 | 160 | 2 | PF13426 | |
| Domain | cNMP-bd_dom | 3.30e-03 | 35 | 160 | 3 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 3.30e-03 | 35 | 160 | 3 | PS50042 | |
| Domain | Prefoldin | 3.40e-03 | 72 | 160 | 4 | IPR009053 | |
| Domain | RRM_dom | 3.47e-03 | 227 | 160 | 7 | IPR000504 | |
| Domain | - | 3.58e-03 | 36 | 160 | 3 | 2.60.200.20 | |
| Domain | FHA_dom | 3.58e-03 | 36 | 160 | 3 | IPR000253 | |
| Domain | RRM | 3.73e-03 | 230 | 160 | 7 | PS50102 | |
| Domain | BAH | 3.81e-03 | 11 | 160 | 2 | PS51038 | |
| Domain | BAH_dom | 3.81e-03 | 11 | 160 | 2 | IPR001025 | |
| Domain | BAH | 3.81e-03 | 11 | 160 | 2 | SM00439 | |
| Domain | BAH | 3.81e-03 | 11 | 160 | 2 | PF01426 | |
| Domain | BROMODOMAIN_1 | 3.87e-03 | 37 | 160 | 3 | PS00633 | |
| Domain | cNMP-bd-like | 4.18e-03 | 38 | 160 | 3 | IPR018490 | |
| Domain | MYB_LIKE | 4.18e-03 | 38 | 160 | 3 | PS50090 | |
| Domain | - | 5.13e-03 | 244 | 160 | 7 | 3.30.70.330 | |
| Domain | Pkinase | 5.65e-03 | 381 | 160 | 9 | PF00069 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 6.20e-03 | 14 | 160 | 2 | IPR003938 | |
| Domain | P-loop_NTPase | DDX19A MYH3 MYH10 MYH13 MYO18A FANCM DDX5 NPHP3 SULT2A1 ATAD2B IQCB1 MYH15 RAB2A MX2 DNAH11 | 6.28e-03 | 848 | 160 | 15 | IPR027417 |
| Domain | Nucleotide-bd_a/b_plait | 6.91e-03 | 258 | 160 | 7 | IPR012677 | |
| Domain | Kinase-like_dom | CDK8 TRIB2 CDC42BPA GRK5 RET NEK1 LATS1 MACF1 PRKG2 PEAK1 MAPK7 | 7.10e-03 | 542 | 160 | 11 | IPR011009 |
| Domain | - | 7.12e-03 | 15 | 160 | 2 | 1.25.40.180 | |
| Domain | MIF4-like | 7.12e-03 | 15 | 160 | 2 | IPR016021 | |
| Domain | - | 8.05e-03 | 48 | 160 | 3 | 2.60.120.10 | |
| Pathway | REACTOME_MRNA_SPLICING | 6.19e-05 | 201 | 122 | 9 | MM15411 | |
| Pathway | REACTOME_MRNA_SPLICING | 9.33e-05 | 212 | 122 | 9 | M14033 | |
| Pathway | WP_BARDETBIEDL_SYNDROME | 1.13e-04 | 88 | 122 | 6 | M45557 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.45e-04 | 277 | 122 | 10 | MM15414 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.73e-04 | 283 | 122 | 10 | M13087 | |
| Pathway | WP_CILIOPATHIES | 1.96e-04 | 184 | 122 | 8 | M39880 | |
| Pubmed | UNC13B TPM4 SART3 MRE11 SRRM1 MYH10 CDC42BPA MYH13 DSP PPFIA1 KRI1 SRSF11 SNX33 AIP MORC2 TTF1 TRIP12 PRPF40A SF1 GTF3C3 NGDN CEP170 TXLNA RBM25 FAM120A SULT2A1 RBM27 NOM1 MKI67 PUM3 CEP131 CLINT1 PLEC ARHGEF2 QARS1 TIMM44 RAB2A SLC39A7 MX2 DNMT1 | 7.24e-21 | 1371 | 163 | 40 | 36244648 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SART3 TPR UIMC1 MRE11 SRRM1 CALD1 DSP POLR2A NSD1 KRI1 SRSF11 FANCM TRIP12 PRPF40A SF1 DDX5 CEP170 RBM25 SAFB RBM27 BRD4 ATAD2B MKI67 ANKRD11 SAFB2 PUM3 CLINT1 TAF1 IK SPEN TOR1AIP1 NIPBL DNMT1 | 2.02e-19 | 954 | 163 | 33 | 36373674 |
| Pubmed | SART3 TPR MRE11 SRRM1 MYH10 DSP POLR2A NSD1 KRI1 TTF1 TRIP12 PRPF40A GTF3C3 CEP170 RBM25 FAM120A ATAD2B SYNE2 MKI67 MACF1 UTP20 PUM3 PLEC IK SPEN NIPBL DNMT1 | 6.63e-18 | 653 | 163 | 27 | 22586326 | |
| Pubmed | TPR MRE11 CALD1 ANK3 DSP POLR2A CAPZA1 NSD1 MCCC2 MBIP PRPF40A GTF3C3 CEP170 NEK1 RBM25 LATS1 RBM27 BRD4 PSME3 CLINT1 TAF1 PEAK1 IK SPEN DNMT1 | 1.30e-17 | 549 | 163 | 25 | 38280479 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | UIMC1 MRE11 SRRM1 TCF7L2 DSP POLR2A GPS2 UBQLN4 NSD1 SRSF11 RNF40 MCCC2 FANCM TTF1 TRIP12 MBIP PRPF40A ESCO1 SF1 DDX5 NGDN RBM25 SAFB RBM27 NOM1 BRD4 MKI67 ANKRD11 SAFB2 UTP20 IK SPEN TOR1AIP1 NIPBL DNMT1 | 3.06e-17 | 1294 | 163 | 35 | 30804502 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR UIMC1 MRE11 SRRM1 DSP POLR2A MYO18A TATDN2 UBA2 SNX33 MORC2 TRIP12 PRPF40A SF1 RBM25 SAFB LATS1 BRD4 MKI67 SAFB2 UTP20 RERE PLEC ARHGEF2 SPEN NIPBL DNMT1 | 4.47e-16 | 774 | 163 | 27 | 15302935 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SART3 TPR MRE11 DDX19A MYH10 DSP POLR2A CAPZA1 KRI1 MCCC2 PRPF40A SF1 GTF3C3 DDX5 STX12 TXLNA RBM25 SAFB FAM120A MKI67 SAFB2 CC2D2A UTP20 PUM3 PSME3 CLINT1 PEAK1 IK QARS1 SPEN TIMM44 RAB2A TOR1AIP1 NIPBL DNMT1 | 5.74e-16 | 1425 | 163 | 35 | 30948266 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TPM4 SART3 TPR MRE11 MYH10 DSP CAPZA1 MYO18A KRI1 TRIP12 SF1 GTF3C3 DDX5 NGDN CEP170 PTPN2 TXLNA RBM25 SAFB FAM120A RBM27 NOM1 MKI67 SAFB2 UTP20 PUM3 CLINT1 PLEC ARHGEF2 IK QARS1 SPEN DNMT1 | 6.70e-16 | 1257 | 163 | 33 | 36526897 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TPR MRE11 SRRM1 DDX19A CALD1 DSP POLR2A CAPZA1 SRSF11 TRIP12 PRPF40A SF1 DDX5 CEP170 RBM25 SAFB SYNE2 MKI67 SAFB2 MACF1 UTP20 PUM3 CEP131 PLEC ARHGEF2 IK QARS1 SPEN TOR1AIP1 NIPBL | 9.41e-16 | 1024 | 163 | 30 | 24711643 |
| Pubmed | TPM4 TPR SRRM1 CDC42BPA MYH13 DSP PPFIA1 NSD1 KRI1 GON4L TRIP12 PRPF40A FER1L6 DDX5 NOM1 MACF1 PLEC | 1.33e-15 | 234 | 163 | 17 | 36243803 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | SART3 TPR MRE11 MYH10 WDR70 KRI1 TRIP12 SF1 DDX5 RBM27 BRD4 MKI67 SAFB2 PSME3 TAF1 IK SPEN DNMT1 | 1.92e-15 | 283 | 163 | 18 | 30585729 |
| Pubmed | TPR MRE11 SRRM1 MYH10 CDC42BPA CAPZA1 KRI1 SRSF11 TRIP12 PRPF40A SF1 GTF3C3 DDX5 NGDN RBM25 SAFB FAM120A RBM27 NOM1 MKI67 SAFB2 UTP20 PUM3 IK QARS1 TOR1AIP1 SLC39A7 | 4.00e-15 | 847 | 163 | 27 | 35850772 | |
| Pubmed | TPM4 SART3 UIMC1 SRRM1 FAM184B MYH3 MYH10 MYH13 CALD1 DSP PPFIA1 GRK5 CAPZA1 MYO18A SRSF11 TRIP12 FER1L6 DDX5 NGDN PSME3IP1 SAFB UBXN4 LATS1 SYNE2 CFAP45 SAFB2 CC2D2A MACF1 MYH15 PLEC ARHGEF2 TNNT1 SPEN NIPBL | 5.29e-15 | 1442 | 163 | 34 | 35575683 | |
| Pubmed | SART3 TPR UIMC1 MRE11 SRRM1 POLR2A WDR70 UBA2 RNF40 AIP MORC2 PRPF40A SF1 GTF3C3 PSME3IP1 PTPN2 RBM25 SAFB RBM27 PPP4R2 BRD4 MKI67 SAFB2 PSME3 TAF1 PLEC IK NIPBL DNMT1 | 5.57e-15 | 1014 | 163 | 29 | 32416067 | |
| Pubmed | TPM4 UIMC1 MRE11 MYH10 TCF7L2 TCF12 CDC42BPA GPS2 MYO18A KRI1 GON4L RELA MCCC2 BCL7A MORC2 MBIP ZBTB1 PRPF40A GTF3C3 RBM25 FAM120A RBM27 SYNE2 MKI67 AUTS2 PUM3 CEP131 PSME3 TAF1 RERE QARS1 SPEN NIPBL | 2.55e-14 | 1429 | 163 | 33 | 35140242 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPM4 SART3 TPR UIMC1 MRE11 MYH10 CALD1 DSP POLR2A WDR70 CAPZA1 PRPF40A SF1 DDX5 CEP170 PSME3IP1 NEK1 SAFB RBM27 MKI67 SAFB2 MACF1 PSME3 CLINT1 TOR1AIP1 NIPBL DNMT1 | 4.17e-14 | 934 | 163 | 27 | 33916271 |
| Pubmed | CDK8 MRE11 TCF7L2 TCF12 GPS2 CAPZA1 UBA2 AIP MORC2 SF1 DDX5 CEP170 TXLNA SAFB FAM120A RBM27 PPP4R2 BRD4 MKI67 SAFB2 PUM3 PSME3 CLINT1 ARHGEF2 IK SPEN RAB2A NIPBL DNMT1 | 4.70e-14 | 1103 | 163 | 29 | 34189442 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | TPM4 SRRM1 MYH10 CDC42BPA DSP POLR2A MYO18A SRSF11 BCL7A TRIP12 PRPF40A SF1 GTF3C3 DDX5 CEP170 RBM25 SAFB RBM27 BRD4 CFAP45 SAFB2 MACF1 PLEC ARHGEF2 IK SPEN NKAPL NIPBL | 2.00e-13 | 1082 | 163 | 28 | 38697112 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SART3 TPR MRE11 DDX19A MYH10 DSP POLR2A WDR70 CAPZA1 SNX33 MCCC2 TRIP12 GTF3C3 DDX5 NGDN SAFB FAM120A MKI67 SAFB2 MACF1 UTP20 PUM3 PSME3 PLEC ARHGEF2 IK QARS1 TIMM44 NEXN NIPBL DNMT1 | 2.15e-13 | 1353 | 163 | 31 | 29467282 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | MYO18A CENPU KRI1 TTF1 TRIP12 GTF3C3 DDX5 NGDN CEP170 TXLNA FAM120A RBM27 NOM1 IQCB1 MKI67 SAFB2 MACF1 UTP20 PUM3 ARHGEF2 IK QARS1 DNMT1 | 1.47e-12 | 759 | 163 | 23 | 35915203 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SRRM1 CDC42BPA DSP PPFIA1 RAB11FIP2 SRSF11 TRIP12 CEP170 NEK1 RADIL CCDC88A LATS1 BRD4 SYNE2 IQCB1 ANKRD11 MACF1 CEP131 CLINT1 PEAK1 PLEC ARHGEF2 DNMT1 CCSER1 | 2.67e-12 | 861 | 163 | 24 | 36931259 |
| Pubmed | TPR DSP PPFIA1 UBQLN4 RNF40 MCCC2 MBIP ZBTB1 GTF3C3 NEK1 CCDC88A BRD4 CEP131 TAF1 RERE PLEC SLC39A7 | 1.60e-11 | 418 | 163 | 17 | 34709266 | |
| Pubmed | SRRM1 TCF12 CDC42BPA MYH13 ANK3 PPFIA1 MAGEC3 RELA MCCC2 TRIP12 GTF3C3 UBXN4 CCDC88A NOM1 MKI67 CEP131 PSME3 CLINT1 PEAK1 SPEN TOR1AIP1 DNMT1 | 1.74e-11 | 777 | 163 | 22 | 35844135 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | TPM4 TPR UIMC1 SRRM1 MYH10 CALD1 DSP CAPZA1 MYO18A PRPF40A DDX5 NGDN RBM25 SAFB FAM120A NOM1 MKI67 SAFB2 UTP20 CLINT1 PLEC ARHGEF2 IK NEXN | 2.02e-11 | 949 | 163 | 24 | 36574265 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | MRE11 SRRM1 DDX19A MYH10 UBA2 KRI1 SRSF11 MCCC2 TTF1 TRIP12 PRPF40A SF1 DDX5 NGDN RBM25 SAFB FAM120A CCDC71 RBM27 MKI67 SAFB2 PLEC ARHGEF2 QARS1 TIMM44 RAB2A NIPBL DNMT1 | 2.14e-11 | 1318 | 163 | 28 | 30463901 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MRE11 CALD1 PPFIA1 CAPZA1 MYO18A MORC2 TRIP12 SF1 NGDN CEP170 TXLNA FAM120A RBM27 NOM1 MKI67 MACF1 CLINT1 PLEC IK QARS1 SPEN | 3.35e-11 | 724 | 163 | 21 | 36232890 |
| Pubmed | SART3 TPR SRRM1 MYH10 CALD1 WDR70 CAPZA1 SRSF11 MBIP PRPF40A SF1 RBM25 PPP4R2 BRD4 MKI67 PSME3 IK QARS1 | 3.53e-11 | 506 | 163 | 18 | 30890647 | |
| Pubmed | SRRM1 MYH10 DSP PPFIA1 POLR2A PRPF40A DDX5 CEP170 RBM25 SAFB BRD4 MKI67 SAFB2 PSME3 IK QARS1 DNMT1 | 3.68e-11 | 441 | 163 | 17 | 31239290 | |
| Pubmed | TPR MRE11 SRRM1 MYH10 CALD1 CAPZA1 MYO18A SRSF11 TRIP12 PRPF40A SF1 DDX5 RBM25 SAFB MKI67 SAFB2 MACF1 CLINT1 PLEC IK | 4.71e-11 | 660 | 163 | 20 | 32780723 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | TPM4 SART3 TPR UIMC1 MRE11 MYH10 MYH13 CALD1 DSP CAPZA1 UBA2 RNF40 PRPF40A DDX5 TXLNA RBM25 UBXN4 MACF1 PLEC QARS1 NIPBL DNMT1 | 9.05e-11 | 847 | 163 | 22 | 35235311 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | TPM4 SART3 TPR MRE11 SRRM1 MYH10 CALD1 ANK3 FNTA DSP CAPZA1 MYO18A UBA2 AIP PRPF40A SF1 GTF3C3 DDX5 CEP170 FAM120A RBM27 IQCB1 MACF1 PLEC QARS1 | 1.76e-10 | 1149 | 163 | 25 | 35446349 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | MYH10 DSP POLR2A KRI1 SRSF11 MCCC2 TRIP12 PRPF40A SF1 GTF3C3 DDX5 NGDN RBM25 SAFB RBM27 MKI67 SAFB2 UTP20 PUM3 PLEC IK QARS1 DNMT1 | 2.83e-10 | 989 | 163 | 23 | 36424410 |
| Pubmed | TPM4 SART3 MYH10 POLR2A CENPU KRI1 RNF40 MCCC2 DDX5 TXLNA RBM25 SAFB RBM27 SAFB2 PSME3 CLINT1 IK TIMM44 DNMT1 | 2.93e-10 | 653 | 163 | 19 | 33742100 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TPR MRE11 SRRM1 DDX19A DSP PPFIA1 CAPZA1 SRSF11 TRIP12 PRPF40A DDX5 BRD4 MACF1 CLINT1 PLEC ARHGEF2 IK NIPBL | 3.37e-10 | 582 | 163 | 18 | 20467437 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CDK8 MYH10 TCF7L2 CDC42BPA CALD1 ANK3 SDCCAG8 WDR70 CAPZA1 SRSF11 CTIF MCCC2 TTF1 F7 ADCY1 ESCO1 CEP170 SNX30 ARHGAP6 FAM120A GUCY1A1 KIAA1328 ANKRD11 AUTS2 CDYL2 MACF1 WDR45B RERE | 3.48e-10 | 1489 | 163 | 28 | 28611215 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | SART3 MRE11 LCA5 ANK3 SDCCAG8 RAB11FIP2 WDR70 CAPZA1 SNX33 IFT43 DDX5 DNALI1 CEP170 NEK1 TXLNA NPHP3 CCDC88A USH1G PPP4R2 IQCB1 CEP131 CLINT1 PRKG2 PLEC QARS1 RAB2A | 6.20e-10 | 1321 | 163 | 26 | 27173435 |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 6.36e-10 | 130 | 163 | 10 | 35545047 | |
| Pubmed | SART3 MYH10 CDC42BPA MYO18A KRI1 PRPF40A DDX5 CEP170 SAFB FAM120A RBM27 PLEC IK | 6.68e-10 | 274 | 163 | 13 | 34244482 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SART3 TPR MRE11 MYH10 TCF12 DSP POLR2A GPS2 WDR70 RELA SNX33 MORC2 TTF1 TRIP12 GTF3C3 PSME3IP1 FAM120A UTP20 ARHGEF2 QARS1 SPEN | 7.14e-10 | 857 | 163 | 21 | 25609649 |
| Pubmed | MRE11 MYH10 CALD1 DSP CAPZA1 TRIP12 PRPF40A DDX5 RBM25 RBM27 CLINT1 ARHGEF2 RAB2A NIPBL | 9.08e-10 | 340 | 163 | 14 | 24332808 | |
| Pubmed | TPR MRE11 CDC42BPA CALD1 ANK3 DSP PPFIA1 CAPZA1 PRPF40A DDX5 CEP170 RBM25 CCDC88A LATS1 MACF1 CLINT1 PEAK1 QARS1 TIMM44 | 1.12e-09 | 708 | 163 | 19 | 39231216 | |
| Pubmed | TPM4 TPR MYH10 CDC42BPA ANK3 DSP MYO18A RELA CCDC88A LATS1 KIAA1328 IRAG2 MACF1 TAF1 PLEC MAPK7 | 1.40e-09 | 486 | 163 | 16 | 20936779 | |
| Pubmed | MYH3 TCF12 CDC42BPA DSP GON4L SF1 CEP170 NPHP3 FAM120A SYNE2 MACF1 PUM3 PSME3 TAF1 PLEC TNNT1 | 1.93e-09 | 497 | 163 | 16 | 23414517 | |
| Pubmed | SART3 SRRM1 DSP SRSF11 MCCC2 PRPF40A DDX5 RBM25 FAM120A PPP4R2 NOM1 MKI67 UTP20 PUM3 RERE PLEC MAPK7 QARS1 | 2.17e-09 | 655 | 163 | 18 | 35819319 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TPM4 SART3 TPR MRE11 SRRM1 MYH10 DSP POLR2A CAPZA1 KRI1 RNF40 MCCC2 SF1 DDX5 CEP170 TXLNA SYNE2 MACF1 PSME3 PLEC ARHGEF2 IK QARS1 TIMM44 NIPBL DNMT1 | 2.61e-09 | 1415 | 163 | 26 | 28515276 |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | UNC13B CCDC91 UIMC1 SRRM1 DDX19A POLR2A CAPZA1 CENPU TATDN2 KRI1 FANCM PRPF40A RBM25 SAFB CCDC88A NOM1 MKI67 NKAPL | 3.10e-09 | 670 | 163 | 18 | 22990118 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SART3 UIMC1 TCF12 CALD1 WDR70 RNF40 PRPF40A SF1 DDX5 CEP170 PSME3IP1 SAFB PSME3 CLINT1 IK | 3.31e-09 | 444 | 163 | 15 | 34795231 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | LCA5 MYH10 CALD1 DSP SDCCAG8 CAPZA1 RIBC1 KRI1 RELA CTIF MCCC2 AIP TXLNA CCDC88A LATS1 FAM120A CLINT1 PLEC ARHGEF2 TIMM44 | 3.95e-09 | 853 | 163 | 20 | 28718761 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | TPR MRE11 SRRM1 MYH10 DSP KRI1 PRPF40A DDX5 NGDN RBM25 SAFB FAM120A NOM1 MKI67 PUM3 IK SPEN | 4.49e-09 | 605 | 163 | 17 | 28977666 |
| Pubmed | MYH10 CDC42BPA ANK3 DSP PPFIA1 POLR2A KRI1 RELA AIP PTPN2 UBXN4 CCDC88A PPP4R2 SYNE2 KIAA1328 MKI67 CEP131 CLINT1 PEAK1 ARHGEF2 IK DNMT1 | 4.74e-09 | 1049 | 163 | 22 | 27880917 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | TPM4 GRK5 POLR2A WDR70 TRIP12 CEP170 TXLNA SAFB FAM120A RBM27 SAFB2 PSME3 CLINT1 PLEC ARHGEF2 IK FMNL1 DNMT1 | 6.24e-09 | 701 | 163 | 18 | 30196744 |
| Pubmed | SART3 SRRM1 POLR2A KRI1 TRIP12 PRPF40A NGDN CEP170 RBM25 MKI67 UTP20 PUM3 TOR1AIP1 | 6.75e-09 | 332 | 163 | 13 | 25693804 | |
| Pubmed | TPR MRE11 SRRM1 UBQLN4 SRSF11 AIP PRPF40A SF1 CEP170 TXLNA RBM25 SAFB BRD4 MKI67 | 7.01e-09 | 399 | 163 | 14 | 35987950 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | SART3 SRRM1 MYH10 FNTA DSP POLR2A PCDHB5 RAB11FIP2 GPS2 CAPZA1 UBA2 SRSF11 PRPF40A GTF3C3 DDX5 RADIL TXLNA RBM25 CCDC82 PPP4R2 NOM1 PSME3 ARHGEF2 SLC39A7 | 8.26e-09 | 1284 | 163 | 24 | 17353931 |
| Pubmed | SART3 UIMC1 MRE11 CDC42BPA PPFIA1 POLR2A NSD1 GON4L RELA BCL7A MORC2 TTF1 NGDN UBXN4 RBM27 NOM1 ANKRD11 CDYL2 MACF1 UTP20 PUM3 CEP131 ARHGEF2 IK SPEN NIPBL | 8.28e-09 | 1497 | 163 | 26 | 31527615 | |
| Pubmed | SART3 TPR MYH10 TRIP12 PRPF40A NGDN RBM25 MKI67 SAFB2 UTP20 PUM3 PLEC NIPBL | 8.96e-09 | 340 | 163 | 13 | 29478914 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | SART3 SRRM1 POLR2A MYO18A SRSF11 PRPF40A SF1 DDX5 NGDN RBM25 SAFB FAM120A RBM27 NOM1 SAFB2 MACF1 UTP20 PUM3 SPEN | 9.32e-09 | 807 | 163 | 19 | 22681889 |
| Pubmed | TPR MYH10 CDC42BPA DSP CAPZA1 KRI1 PRPF40A GTF3C3 DDX5 NGDN CEP170 PSME3IP1 TXLNA RBM25 FAM120A PSME3 PLEC ARHGEF2 QARS1 | 9.69e-09 | 809 | 163 | 19 | 32129710 | |
| Pubmed | CDK8 UIMC1 SRRM1 POLR2A GON4L MORC2 TRIP12 MBIP CEP170 TXLNA RBM27 PUM3 CEP131 PSME3 CLINT1 SPEN TOR1AIP1 | 1.15e-08 | 645 | 163 | 17 | 25281560 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | SRRM1 MYH3 CDC42BPA MYH13 CALD1 SNX33 MCCC2 AIP RET CEP170 NEK1 TXLNA LATS1 AUTS2 MYH15 PSME3 PLEC ARHGEF2 MAPK7 NKAPL | 1.16e-08 | 910 | 163 | 20 | 36736316 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | UNC13B SART3 UIMC1 MRE11 LAMB4 MYH10 WDR70 CAPZA1 CENPU KRI1 RNF40 TRIP12 F7 PTPN2 SAFB PSME3 CLINT1 PLEC ARHGEF2 SLC39A7 DNMT1 | 1.17e-08 | 1005 | 163 | 21 | 19615732 |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | TPM4 TPR DDX19A POLR2A GPS2 MCCC2 SYNE2 IQCB1 MKI67 ANKRD11 RERE IK | 1.37e-08 | 289 | 163 | 12 | 23752268 |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | UNC13B SART3 MYH10 POLR2A SDCCAG8 KRI1 ADCY1 SYNE2 MKI67 MACF1 PUM3 TAF1 QARS1 | 1.65e-08 | 358 | 163 | 13 | 32460013 |
| Pubmed | CDK8 TPR SRRM1 MYH10 TCF7L2 CDC42BPA POLR2A GPS2 CAPZA1 SRSF11 MCCC2 TRIP12 PRPF40A SF1 DDX5 RBM25 LATS1 FAM120A MKI67 ARHGEF2 IK QARS1 RAB2A | 2.23e-08 | 1247 | 163 | 23 | 27684187 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | TPM4 MRE11 SRRM1 MYH10 CALD1 DSP CAPZA1 MYO18A RELA PRPF40A SF1 DDX5 STX12 CEP170 PSME3IP1 PTPN2 SAFB UBXN4 SYNE2 PSME3 QARS1 NEXN TOR1AIP1 DNMT1 | 2.71e-08 | 1367 | 163 | 24 | 32687490 |
| Pubmed | SART3 SRRM1 FAM184B CDC42BPA ANK3 PPFIA1 MYO18A KRI1 MCCC2 AIP PRPF40A GTF3C3 PTPN2 TXLNA UBXN4 CCDC88A FAM120A SYNE2 ANKRD11 MACF1 CEP131 PEAK1 TIMM44 TOR1AIP1 DNMT1 | 3.13e-08 | 1487 | 163 | 25 | 33957083 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | UIMC1 SRRM1 TCF7L2 WDR70 NSD1 MORC2 TRIP12 GTF3C3 BRD4 ATAD2B MKI67 PUM3 TAF1 SPEN NIPBL DNMT1 | 3.25e-08 | 608 | 163 | 16 | 36089195 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | TPR MRE11 DSP POLR2A KRI1 SF1 CEP170 CCDC88A RBM27 CLINT1 PLEC | 3.96e-08 | 256 | 163 | 11 | 33397691 |
| Pubmed | TPR MRE11 FAM184B ZWILCH ANK3 PPFIA1 SLFN12 NSD1 TRIP12 CEP63 NPHP3 KCNH1 PPP4R2 SAFB2 MACF1 PEAK1 PLEC IK CCDC171 RAB2A NEXN | 4.24e-08 | 1084 | 163 | 21 | 11544199 | |
| Pubmed | SRRM1 MYH10 CDC42BPA KRI1 SRSF11 PRPF40A GTF3C3 DDX5 CEP170 RBM25 SAFB FAM120A RBM27 MKI67 SAFB2 ARHGEF2 IK | 4.92e-08 | 713 | 163 | 17 | 29802200 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | SART3 MRE11 SRRM1 MYH10 UBQLN4 GON4L BCL7A TRIP12 GTF3C3 RBM27 BRD4 TAF1 QARS1 | 5.06e-08 | 394 | 163 | 13 | 27248496 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | UIMC1 TCF7L2 DSP PCDHB5 PRPF40A SF1 GTF3C3 DDX5 STX12 SAFB SP140L RBM27 NOM1 BRD4 MKI67 SAFB2 AUTS2 RERE PLEC QARS1 RAB2A SLC39A7 | 5.39e-08 | 1203 | 163 | 22 | 29180619 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | TPR UIMC1 MRE11 POLR2A UBA2 DDX5 SAFB SAFB2 TAF1 PLEC NIPBL DNMT1 | 6.29e-08 | 332 | 163 | 12 | 32786267 |
| Pubmed | 6.41e-08 | 210 | 163 | 10 | 16565220 | ||
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | TPM4 SRRM1 UBA2 SRSF11 PRPF40A CEP170 RBM25 ANKRD11 TAF1 PLEC DNMT1 | 6.56e-08 | 269 | 163 | 11 | 29511261 |
| Pubmed | TPM4 SART3 SRRM1 MYH10 TCF7L2 CALD1 CAPZA1 KRI1 SRSF11 SF1 STX12 CEP170 FAM120A NOM1 SYNE2 MKI67 PUM3 PSME3 CLINT1 ARHGEF2 QARS1 TIMM44 NEXN SLC39A7 | 7.16e-08 | 1440 | 163 | 24 | 30833792 | |
| Pubmed | DSP TRIP12 PRPF40A ESCO1 SF1 GTF3C3 DDX5 MKI67 ANKRD11 PLEC NIPBL | 7.34e-08 | 272 | 163 | 11 | 31010829 | |
| Pubmed | TPM4 MYH10 CALD1 DSP CAPZA1 MYO18A MCCC2 SF1 DDX5 RBM25 MACF1 PLEC QARS1 TIMM44 | 8.57e-08 | 488 | 163 | 14 | 31324722 | |
| Pubmed | PIP30/FAM192A is a novel regulator of the nuclear proteasome activator PA28γ. | 8.85e-08 | 47 | 163 | 6 | 29934401 | |
| Pubmed | 9.25e-08 | 118 | 163 | 8 | 30979931 | ||
| Pubmed | CTIF MORC2 FANCM ESCO1 CEP170 NEK1 RADIL NPHP3 FAM120A SAFB2 MACF1 PUM3 PEAK1 CCSER1 | 9.71e-08 | 493 | 163 | 14 | 15368895 | |
| Pubmed | TPR SRRM1 MORC2 TRIP12 SF1 RBM25 SAFB FAM120A RBM27 MKI67 CEP131 ARHGEF2 SPEN NIPBL | 1.24e-07 | 503 | 163 | 14 | 16964243 | |
| Pubmed | TPR MYH10 ANK3 PPFIA1 NSD1 DDN ZBTB1 CEP170 TXLNA CCDC88A FAM120A SYNE2 SAFB2 MACF1 CEP131 ARHGEF2 RAB2A NIPBL DNMT1 | 1.49e-07 | 963 | 163 | 19 | 28671696 | |
| Pubmed | TPR MYH10 CALD1 UBA2 SRSF11 CEP170 SAFB MACF1 PLEC TIMM44 TOR1AIP1 NIPBL | 1.51e-07 | 360 | 163 | 12 | 33111431 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | UNC13B SRRM1 ANK3 WDR70 SRSF11 TRIP12 NGDN CEP170 SAFB MACF1 SPEN FMNL1 | 1.55e-07 | 361 | 163 | 12 | 26167880 |
| Pubmed | MRE11 SRRM1 MYH10 POLR2A MYO18A TRIP12 GTF3C3 CEP170 FAM120A NOM1 MACF1 PLEC ARHGEF2 TIMM44 DNMT1 | 1.76e-07 | 601 | 163 | 15 | 33658012 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SART3 POLR2A RNF40 TRIP12 ZBTB1 GTF3C3 CEP170 RBM27 PPP4R2 MKI67 PUM3 ARHGEF2 QARS1 | 1.81e-07 | 440 | 163 | 13 | 34244565 |
| Pubmed | TPM4 SART3 MYH10 CALD1 ANK3 DSP PPFIA1 CAPZA1 MYO18A PRPF40A DDX5 CEP170 SAFB FAM120A SCN2A MACF1 PEAK1 PLEC ARHGEF2 RAB2A SLC39A7 CACNA2D3 DNAH11 | 2.62e-07 | 1431 | 163 | 23 | 37142655 | |
| Pubmed | 2.88e-07 | 57 | 163 | 6 | 38223760 | ||
| Pubmed | Binding of USP4 to cortactin enhances cell migration in HCT116 human colon cancer cells. | 2.93e-07 | 137 | 163 | 8 | 37039823 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | TPM4 SRRM1 MYH10 TCF7L2 CALD1 DSP CAPZA1 MYO18A MORC2 DDX5 CEP170 TXLNA SAFB MKI67 PLEC | 2.95e-07 | 626 | 163 | 15 | 33644029 |
| Pubmed | SART3 MRE11 WDR70 CAPZA1 KRI1 GON4L AIP GTF3C3 NEK1 RBM25 RBM27 PSME3 IK TIMM44 | 3.41e-07 | 547 | 163 | 14 | 37267103 | |
| Pubmed | TPR UIMC1 SRRM1 MYH10 CALD1 ANK3 POLR2A MYO18A STX12 CEP170 NOM1 MKI67 MACF1 PUM3 CLINT1 | 3.47e-07 | 634 | 163 | 15 | 34591612 | |
| Pubmed | SRRM1 MYH10 DSP KRI1 SRSF11 PRPF40A SF1 DDX5 NGDN RBM25 SAFB RBM27 SAFB2 PUM3 IK SPEN | 3.91e-07 | 731 | 163 | 16 | 29298432 | |
| Pubmed | SART3 TPR MYH10 CDC42BPA ANK3 DSP RAB11FIP2 MYO18A MCCC2 CEP170 PTPN2 SAFB UBXN4 CCDC88A MACF1 CEP131 PEAK1 PLEC TIMM44 SLC39A7 | 4.34e-07 | 1139 | 163 | 20 | 36417873 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | MRE11 SRRM1 MYH10 DSP PRPF40A DDX5 TXLNA RBM25 RBM27 ZNF804B CLINT1 PLEC NEXN | 4.51e-07 | 477 | 163 | 13 | 31300519 |
| Pubmed | SART3 TPR DSP TRIP12 CCDC88A LATS1 CEP131 PSME3 QARS1 RAB2A SLC39A7 DNMT1 | 4.51e-07 | 399 | 163 | 12 | 37536630 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 5.20e-07 | 202 | 163 | 9 | 33005030 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | SART3 TPR ZWILCH CALD1 POLR2A CAPZA1 CENPU BCL7A ESCO1 GTF3C3 DDX5 CEP63 CEP170 FAM120A MKI67 CEP131 CLINT1 NEXN TOR1AIP1 NIPBL | 5.39e-07 | 1155 | 163 | 20 | 20360068 |
| Pubmed | 5.57e-07 | 149 | 163 | 8 | 25184681 | ||
| Interaction | SMC5 interactions | SART3 TPR UIMC1 MRE11 SRRM1 CALD1 DSP POLR2A NSD1 UBA2 KRI1 SRSF11 FANCM TRIP12 PRPF40A SF1 DDX5 CEP170 RADIL RBM25 SAFB RBM27 BRD4 ATAD2B MKI67 ANKRD11 SAFB2 PUM3 CLINT1 TAF1 IK SPEN TOR1AIP1 NIPBL DNMT1 | 1.40e-13 | 1000 | 163 | 35 | int:SMC5 |
| Interaction | SIRT7 interactions | SART3 TPR MRE11 SRRM1 MYH10 DSP POLR2A NSD1 KRI1 TTF1 TRIP12 PRPF40A GTF3C3 CEP170 RBM25 FAM120A BRD4 ATAD2B SYNE2 MKI67 MACF1 UTP20 PUM3 PLEC IK SPEN NIPBL DNMT1 | 1.01e-11 | 744 | 163 | 28 | int:SIRT7 |
| Interaction | CIT interactions | TPM4 TPR SRRM1 MYH10 DSP POLR2A CAPZA1 MYO18A KRI1 RNF40 CTIF TRIP12 PRPF40A SF1 DDX5 CEP170 TAX1BP3 RBM25 SAFB FAM120A RBM27 SYNE2 MKI67 SAFB2 MACF1 UTP20 PUM3 PLEC ARHGEF2 IK QARS1 NKAPL NEXN TOR1AIP1 NIPBL SLC39A7 CCSER1 | 2.74e-10 | 1450 | 163 | 37 | int:CIT |
| Interaction | DOT1L interactions | TPR SRRM1 MYH10 CDC42BPA CAPZA1 KRI1 SRSF11 TRIP12 PRPF40A SF1 GTF3C3 DDX5 NGDN RBM25 SAFB FAM120A RBM27 NOM1 MKI67 SAFB2 UTP20 PUM3 IK MAPK7 QARS1 TOR1AIP1 SLC39A7 | 3.45e-10 | 807 | 163 | 27 | int:DOT1L |
| Interaction | MEN1 interactions | SART3 MRE11 SRRM1 MYH10 TCF7L2 CDC42BPA POLR2A CAPZA1 KRI1 RELA TRIP12 PRPF40A SF1 GTF3C3 DDX5 RBM25 SAFB FAM120A NOM1 MKI67 SAFB2 UTP20 PUM3 TAF1 RERE IK QARS1 SPEN TOR1AIP1 SLC39A7 | 8.53e-10 | 1029 | 163 | 30 | int:MEN1 |
| Interaction | YWHAH interactions | LCA5 SRRM1 CDC42BPA DSP PPFIA1 RAB11FIP2 SNX33 TRIP12 CEP170 LNP1 PSME3IP1 NEK1 RADIL CCDC88A LATS1 KCNH2 BRD4 SYNE2 IQCB1 ANKRD11 CC2D2A MACF1 CEP131 CLINT1 PEAK1 PLEC ARHGEF2 MAPK7 DNMT1 TPH1 CCSER1 | 1.01e-09 | 1102 | 163 | 31 | int:YWHAH |
| Interaction | TERF2IP interactions | UIMC1 MRE11 WDR70 NSD1 UBA2 SRSF11 RNF40 TRIP12 PRPF40A GTF3C3 RBM27 BRD4 MKI67 ANKRD11 PSME3 TAF1 IK SPEN TOR1AIP1 NIPBL DNMT1 | 4.16e-09 | 552 | 163 | 21 | int:TERF2IP |
| Interaction | CEBPA interactions | CDK8 MRE11 TCF7L2 TRIB2 TCF12 POLR2A GPS2 CAPZA1 UBA2 AIP MORC2 SF1 DDX5 CEP170 TXLNA SAFB FAM120A RBM27 PPP4R2 BRD4 MKI67 SAFB2 MACF1 PUM3 PSME3 CLINT1 ARHGEF2 IK SPEN RAB2A NIPBL DNMT1 | 4.72e-09 | 1245 | 163 | 32 | int:CEBPA |
| Interaction | HECTD1 interactions | MYH10 MYO18A CENPU KRI1 TTF1 TRIP12 PRPF40A GTF3C3 DDX5 NGDN CEP170 TXLNA RBM25 FAM120A RBM27 NOM1 IQCB1 MKI67 ANKRD11 SAFB2 MACF1 UTP20 PUM3 TAF1 ARHGEF2 IK QARS1 DNMT1 | 5.77e-09 | 984 | 163 | 28 | int:HECTD1 |
| Interaction | AR interactions | CDK8 TPM4 SART3 TPR MRE11 DDX19A MYH10 TCF7L2 CDC42BPA DSP GPS2 CAPZA1 MYO18A NSD1 RNF40 RELA BCL7A ZBTB1 PRPF40A DDX5 RBM25 RBM27 BRD4 CEP131 TAF1 RERE IK NIPBL | 6.88e-09 | 992 | 163 | 28 | int:AR |
| Interaction | WWTR1 interactions | MRE11 CALD1 ANK3 POLR2A CAPZA1 MCCC2 TTF1 MBIP PRPF40A CEP170 NEK1 RBM25 LATS1 RBM27 BRD4 CLINT1 PEAK1 DNMT1 | 1.01e-08 | 422 | 163 | 18 | int:WWTR1 |
| Interaction | EED interactions | TPM4 TPR MRE11 SRRM1 MYH10 DSP POLR2A CAPZA1 MYO18A NSD1 UBA2 MCCC2 TRIP12 PRPF40A SF1 GTF3C3 DDX5 RBM25 SAFB CCDC71 NOM1 BRD4 SAFB2 MACF1 UTP20 PUM3 CLINT1 PLEC IK SPEN RAB2A NEXN NIPBL DNMT1 | 1.31e-08 | 1445 | 163 | 34 | int:EED |
| Interaction | IFI16 interactions | SART3 TPR SRRM1 POLR2A KRI1 SRSF11 RNF40 TRIP12 PRPF40A GTF3C3 DDX5 NGDN CEP170 RBM25 SAFB BRD4 MKI67 SAFB2 UTP20 PUM3 QARS1 TOR1AIP1 DNMT1 | 1.64e-08 | 714 | 163 | 23 | int:IFI16 |
| Interaction | OBSL1 interactions | TPR MRE11 SRRM1 CALD1 DSP POLR2A CAPZA1 SRSF11 TRIP12 PRPF40A SF1 DDX5 RBM25 SAFB SYNE2 CFAP45 MKI67 SAFB2 MACF1 UTP20 PUM3 PLEC IK SPEN RAB2A NIPBL | 1.68e-08 | 902 | 163 | 26 | int:OBSL1 |
| Interaction | USP7 interactions | CDK8 TPM4 TPR MRE11 SRRM1 MYH3 TCF7L2 TCF12 CDC42BPA MYH13 DSP PPFIA1 RIBC1 NSD1 KRI1 GON4L RELA TRIP12 F7 PRPF40A IFT43 FER1L6 DDX5 RADIL NOM1 BRD4 SCN2A CFAP45 MACF1 TAF1 PLEC DNMT1 | 1.68e-08 | 1313 | 163 | 32 | int:USP7 |
| Interaction | NAA40 interactions | TPM4 SART3 TPR UIMC1 MRE11 MYH10 CALD1 DSP POLR2A WDR70 CAPZA1 PRPF40A SF1 DDX5 CEP170 PSME3IP1 NEK1 SAFB RBM27 MKI67 SAFB2 MACF1 PSME3 CLINT1 TOR1AIP1 NIPBL DNMT1 | 2.11e-08 | 978 | 163 | 27 | int:NAA40 |
| Interaction | EP300 interactions | TPM4 SART3 MRE11 MYH10 TCF7L2 TCF12 POLR2A GPS2 CENPU KRI1 SRSF11 RNF40 RELA MCCC2 PRPF40A SF1 GTF3C3 DDX5 TXLNA RBM25 SAFB RBM27 BRD4 SAFB2 AUTS2 PSME3 CLINT1 RERE IK QARS1 TIMM44 RAB2A DNMT1 | 2.19e-08 | 1401 | 163 | 33 | int:EP300 |
| Interaction | MECP2 interactions | TPM4 SRRM1 MYH10 CDC42BPA DSP POLR2A MYO18A NSD1 SRSF11 BCL7A TRIP12 PRPF40A SF1 GTF3C3 DDX5 CEP170 RBM25 SAFB RBM27 BRD4 CFAP45 MKI67 SAFB2 MACF1 PLEC ARHGEF2 IK SPEN NKAPL NIPBL DNMT1 | 3.83e-08 | 1287 | 163 | 31 | int:MECP2 |
| Interaction | ACTC1 interactions | SART3 TPR SRRM1 MYH10 CALD1 WDR70 CAPZA1 SRSF11 BCL7A MBIP PRPF40A SF1 RBM25 PPP4R2 BRD4 SYNE2 MKI67 PSME3 PLEC IK QARS1 NEXN | 4.60e-08 | 694 | 163 | 22 | int:ACTC1 |
| Interaction | YAP1 interactions | TPR MRE11 MYH10 CALD1 ANK3 DSP POLR2A WDR70 CAPZA1 NSD1 DDN UBA2 RELA MCCC2 GTF3C3 DDX5 CEP170 RBM25 LATS1 FAM120A BRD4 PSME3 CLINT1 TAF1 PLEC IK SPEN DNMT1 | 5.65e-08 | 1095 | 163 | 28 | int:YAP1 |
| Interaction | H3C1 interactions | TPR UIMC1 MYH10 ANK3 DSP POLR2A MYO18A NSD1 KRI1 RET MORC2 TRIP12 ESCO1 GTF3C3 PIEZO2 BRD4 MKI67 CDYL2 MYH15 TAF1 IK SPEN TIMM44 NIPBL DNMT1 | 6.83e-08 | 901 | 163 | 25 | int:H3C1 |
| Interaction | HDAC1 interactions | TPR MYH10 TCF7L2 CDC42BPA PPFIA1 GPS2 UBQLN4 GON4L RNF40 RELA MCCC2 MBIP ZBTB1 ESCO1 DDX5 NEK1 RBM25 CCDC71 BRD4 SYNE2 MKI67 CEP131 TAF1 RERE PLEC SPEN SLC39A7 DNMT1 | 7.23e-08 | 1108 | 163 | 28 | int:HDAC1 |
| Interaction | BIRC3 interactions | SART3 TPR MRE11 DDX19A DSP POLR2A CAPZA1 KRI1 RELA MCCC2 PRPF40A SF1 GTF3C3 DDX5 STX12 TXLNA RBM25 SAFB MKI67 CC2D2A UTP20 PSME3 CLINT1 PEAK1 IK QARS1 SPEN TIMM44 RAB2A TOR1AIP1 DNMT1 | 8.61e-08 | 1334 | 163 | 31 | int:BIRC3 |
| Interaction | KCNA3 interactions | TPR MRE11 SRRM1 CDC42BPA CALD1 ANK3 DSP PPFIA1 CAPZA1 MYO18A MORC2 PRPF40A SF1 DDX5 CEP170 RBM25 CCDC88A LATS1 MACF1 CLINT1 PEAK1 QARS1 SPEN TIMM44 | 1.47e-07 | 871 | 163 | 24 | int:KCNA3 |
| Interaction | OFD1 interactions | MRE11 LCA5 DSP SDCCAG8 UBA2 AIP CEP63 CEP170 TXLNA LATS1 KIAA1328 CC2D2A CEP131 QARS1 RAB2A | 1.54e-07 | 347 | 163 | 15 | int:OFD1 |
| Interaction | EGLN3 interactions | MRE11 TCF12 PPFIA1 POLR2A GPS2 CAPZA1 TATDN2 RNF40 RELA MCCC2 AIP ZBTB1 GTF3C3 CEP170 RADIL TXLNA CCDC88A RBM27 NOM1 BRD4 IQCB1 ANKRD11 PSME3 CLINT1 PEAK1 IK MAPK7 TIMM44 TOR1AIP1 SLC39A7 | 1.57e-07 | 1296 | 163 | 30 | int:EGLN3 |
| Interaction | NUP43 interactions | SRRM1 DSP NSD1 KRI1 GON4L MCCC2 MORC2 TTF1 TRIP12 MBIP SAFB CCDC88A ATAD2B SYNE2 MKI67 ANKRD11 UTP20 RERE SPEN NIPBL | 1.71e-07 | 625 | 163 | 20 | int:NUP43 |
| Interaction | SIRT6 interactions | SART3 DSP POLR2A CAPZA1 RNF40 RELA TRIP12 ZBTB1 GTF3C3 CEP170 TXLNA RBM27 PPP4R2 BRD4 IQCB1 MKI67 PUM3 CEP131 ARHGEF2 QARS1 | 1.84e-07 | 628 | 163 | 20 | int:SIRT6 |
| Interaction | PARP1 interactions | CDK8 UIMC1 MRE11 SRRM1 MYH10 TCF7L2 TRIB2 CALD1 POLR2A WDR70 CAPZA1 NSD1 UBA2 KRI1 RELA MORC2 TRIP12 PRPF40A SF1 GTF3C3 CEP170 PSME3IP1 PTPN2 RBM25 BRD4 MKI67 UTP20 NIPBL FMNL1 DNMT1 | 2.19e-07 | 1316 | 163 | 30 | int:PARP1 |
| Interaction | YWHAZ interactions | LCA5 MYH10 CDC42BPA PPFIA1 GRK5 RAB11FIP2 MYO18A SNX33 TRIP12 CEP170 LNP1 NEK1 RADIL TXLNA CCDC88A LATS1 RBM27 BRD4 SYNE2 IRAG2 MACF1 PUM3 CEP131 PEAK1 PLEC ARHGEF2 MAPK7 DNMT1 TPH1 CCSER1 | 2.30e-07 | 1319 | 163 | 30 | int:YWHAZ |
| Interaction | CBX3 interactions | CDK8 UIMC1 SRRM1 TCF7L2 POLR2A WDR70 NSD1 UBA2 TRIM39 MORC2 TRIP12 CCDC71 RBM27 BRD4 MKI67 MACF1 SPEN TOR1AIP1 NIPBL DNMT1 | 2.89e-07 | 646 | 163 | 20 | int:CBX3 |
| Interaction | CUL7 interactions | TPM4 TPR MRE11 CALD1 DSP POLR2A CAPZA1 SNX33 PRPF40A SF1 DDX5 RBM25 SAFB KCNH1 SYNE2 MKI67 SAFB2 MACF1 PLEC IK QARS1 SPEN NEXN | 3.40e-07 | 845 | 163 | 23 | int:CUL7 |
| Interaction | NXF1 interactions | TPR UIMC1 SRRM1 DDX19A TCF12 GRK5 POLR2A UBQLN4 CAPZA1 MYO18A TATDN2 RNF40 MORC2 SF1 DDX5 MEOX1 PSME3IP1 TXLNA RBM25 FAM120A RBM27 BRD4 MKI67 CDYL2 MACF1 PUM3 PSME3 TAF1 ARHGEF2 QARS1 | 3.48e-07 | 1345 | 163 | 30 | int:NXF1 |
| Interaction | DDX23 interactions | SRRM1 MYH10 WDR70 KRI1 SRSF11 MORC2 PRPF40A DDX5 RBM25 SAFB BRD4 ANKRD11 SAFB2 UTP20 PUM3 TAF1 IK | 3.78e-07 | 480 | 163 | 17 | int:DDX23 |
| Interaction | HDLBP interactions | SART3 SRRM1 DSP PPFIA1 SRSF11 SNX33 MORC2 TTF1 PRPF40A SF1 GTF3C3 NGDN CEP170 RBM25 FAM120A RBM27 MKI67 MYH16 CLINT1 ARHGEF2 QARS1 RAB2A DNMT1 | 4.18e-07 | 855 | 163 | 23 | int:HDLBP |
| Interaction | XRCC6 interactions | SART3 TPR MRE11 MYH10 TCF7L2 WDR70 CENPU NSD1 KRI1 RELA TRIP12 PRPF40A SF1 DDX5 RBM27 BRD4 MKI67 SAFB2 PSME3 TAF1 IK SPEN FMNL1 DNMT1 | 4.63e-07 | 928 | 163 | 24 | int:XRCC6 |
| Interaction | CEBPB interactions | CDK8 TPM4 TPR MRE11 SRRM1 DDX19A DSP POLR2A CAPZA1 UBA2 SRSF11 RELA AIP PRPF40A SF1 DDX5 NGDN CEP170 PSME3IP1 TXLNA RBM25 BRD4 MKI67 SAFB2 PLEC IK MAPK7 QARS1 TIMM44 TOR1AIP1 DNMT1 | 4.85e-07 | 1443 | 163 | 31 | int:CEBPB |
| Interaction | RCOR1 interactions | TPR MYH10 DSP PPFIA1 GPS2 RNF40 MCCC2 MBIP ZBTB1 NEK1 CCDC88A BRD4 MKI67 CEP131 TAF1 PLEC SPEN | 5.64e-07 | 494 | 163 | 17 | int:RCOR1 |
| Interaction | KDM1A interactions | TPR DSP PPFIA1 POLR2A UBQLN4 UBA2 TRIM39 RNF40 RELA MCCC2 ZBTB1 ESCO1 GTF3C3 NEK1 CCDC88A BRD4 ANKEF1 CEP131 TAF1 RERE PLEC IK SLC39A7 DNMT1 | 5.94e-07 | 941 | 163 | 24 | int:KDM1A |
| Interaction | NUPR1 interactions | TPR MRE11 SRRM1 MYH10 CALD1 CAPZA1 MYO18A SRSF11 TRIP12 PRPF40A SF1 DDX5 RBM25 SAFB MKI67 SAFB2 MACF1 CLINT1 PLEC IK | 6.92e-07 | 683 | 163 | 20 | int:NUPR1 |
| Interaction | HOOK3 interactions | MRE11 MYH10 PPFIA1 CAPZA1 KRI1 RELA CTIF CEP63 CCDC88A FAM120A PLEC | 7.94e-07 | 202 | 163 | 11 | int:HOOK3 |
| Interaction | PHF21A interactions | TPR MYH13 DSP PPFIA1 RNF40 MCCC2 MBIP ZBTB1 NEK1 CCDC88A BRD4 CEP131 TAF1 PLEC | 8.08e-07 | 343 | 163 | 14 | int:PHF21A |
| Interaction | YWHAG interactions | LCA5 SRRM1 MYH10 CDC42BPA DSP PPFIA1 GRK5 RAB11FIP2 SRSF11 SNX33 TRIP12 PRPF40A CEP170 LNP1 NEK1 RADIL CCDC88A LATS1 SYNE2 ANKRD11 MACF1 CEP131 CLINT1 PEAK1 ARHGEF2 MAPK7 DNMT1 CCSER1 | 8.13e-07 | 1248 | 163 | 28 | int:YWHAG |
| Interaction | BRCA1 interactions | CDK8 SART3 TPR UIMC1 MRE11 MYH10 FNTA DSP PPFIA1 POLR2A CAPZA1 CENPU TATDN2 RELA FANCM ZBTB1 DDX5 CEP170 TXLNA FAM120A BRD4 MKI67 PSME3 PLEC QARS1 NKAPL NIPBL DNMT1 | 8.27e-07 | 1249 | 163 | 28 | int:BRCA1 |
| Interaction | KIF23 interactions | SRRM1 ZWILCH MYH10 DSP CENPU NSD1 KRI1 PRPF40A DDX5 NGDN CEP170 TXLNA RBM25 SAFB LATS1 FAM120A BRD4 MKI67 SAFB2 MACF1 PUM3 PLEC ARHGEF2 TIMM44 SLC39A7 | 8.52e-07 | 1031 | 163 | 25 | int:KIF23 |
| Interaction | MAD2L1 interactions | SART3 TPR FANCM MBIP UBXN4 CCDC88A BRD4 IQCB1 MACF1 PEAK1 TOR1AIP1 SLC39A7 | 1.03e-06 | 252 | 163 | 12 | int:MAD2L1 |
| Interaction | CAPZB interactions | TPM4 TPR UIMC1 MYH10 CALD1 PPFIA1 UBQLN4 CAPZA1 MYO18A UBA2 RNF40 MBIP SF1 DDX5 CEP170 SNX30 FAM120A MKI67 PSME3 CLINT1 PEAK1 ARHGEF2 QARS1 NEXN NIPBL | 1.17e-06 | 1049 | 163 | 25 | int:CAPZB |
| Interaction | SUPT5H interactions | LCA5 POLR2A GPS2 WDR70 RNF40 SF1 DDX5 CCDC71 PPP4R2 BRD4 SYNE2 SAFB2 IK SPEN NIPBL | 1.20e-06 | 408 | 163 | 15 | int:SUPT5H |
| Interaction | TAF15 interactions | TPR CALD1 POLR2A SF1 DDX5 CEP63 RBM25 SAFB LATS1 FAM120A BRD4 MKI67 SAFB2 TAF1 IK | 1.20e-06 | 408 | 163 | 15 | int:TAF15 |
| Interaction | KIF20A interactions | TPM4 SRRM1 MYH10 DSP CAPZA1 MYO18A MORC2 PRPF40A SF1 DDX5 CEP170 RBM25 SAFB PIEZO2 BRD4 SYNE2 MKI67 IRAG2 SAFB2 MACF1 PUM3 CLINT1 PLEC IK CCDC171 | 1.23e-06 | 1052 | 163 | 25 | int:KIF20A |
| Interaction | SAP18 interactions | TPR SRRM1 CALD1 GRK5 SRSF11 RELA PRPF40A RBM25 SAFB LATS1 BRD4 TAF1 IK | 1.25e-06 | 305 | 163 | 13 | int:SAP18 |
| Interaction | SNRNP70 interactions | CDK8 TPM4 TPR SRRM1 MYH10 CDC42BPA POLR2A KRI1 SRSF11 RELA PRPF40A GTF3C3 DDX5 CEP63 CEP170 RBM25 SAFB FAM120A RBM27 BRD4 MKI67 SAFB2 ARHGEF2 IK | 1.31e-06 | 984 | 163 | 24 | int:SNRNP70 |
| Interaction | SRPK2 interactions | LCA5 SRRM1 ANK3 POLR2A WDR70 KRI1 SRSF11 TRIP12 PRPF40A DDX5 NGDN CEP170 SAFB RBM27 NOM1 MKI67 MACF1 PUM3 SPEN FMNL1 | 1.46e-06 | 717 | 163 | 20 | int:SRPK2 |
| Interaction | ATG16L1 interactions | TPM4 ANK3 PPFIA1 GRK5 POLR2A RAB11FIP2 WDR70 CAPZA1 TRIP12 STX12 CEP63 CEP170 TXLNA SAFB CCDC88A FAM120A RBM27 SAFB2 CEP131 PSME3 CLINT1 PLEC ARHGEF2 IK FMNL1 DNMT1 | 2.20e-06 | 1161 | 163 | 26 | int:ATG16L1 |
| Interaction | GLDC interactions | SART3 MYH10 CDC42BPA MYO18A KRI1 PRPF40A DDX5 CEP170 SAFB FAM120A RBM27 PLEC IK | 2.21e-06 | 321 | 163 | 13 | int:GLDC |
| Interaction | POLR1G interactions | POLR2A WDR70 NSD1 KRI1 RELA MORC2 TTF1 TRIP12 GTF3C3 BRD4 ANKRD11 UTP20 PUM3 TAF1 IK NIPBL | 2.37e-06 | 489 | 163 | 16 | int:POLR1G |
| Interaction | CSNK2A1 interactions | SART3 SRRM1 TCF7L2 CALD1 POLR2A SRSF11 RELA AIP MORC2 PRPF40A GTF3C3 MEOX1 CEP170 PSME3IP1 SAFB CCDC82 GUCY1A1 BRD4 ANKRD11 AUTS2 MACF1 TAF1 TOR1AIP1 | 2.81e-06 | 956 | 163 | 23 | int:CSNK2A1 |
| Interaction | CDK9 interactions | TPM4 SART3 TPR MYH10 CDC42BPA POLR2A CAPZA1 MYO18A RNF40 RELA AIP TRIP12 PRPF40A DDX5 RBM25 SAFB RBM27 BRD4 PLEC | 2.97e-06 | 685 | 163 | 19 | int:CDK9 |
| Interaction | PHLPP1 interactions | TPR MRE11 DSP POLR2A KRI1 SRSF11 AIP SF1 CEP170 CCDC88A RBM27 CLINT1 PLEC | 3.31e-06 | 333 | 163 | 13 | int:PHLPP1 |
| Interaction | CALM1 interactions | UNC13B TPM4 CALD1 GRK5 MYO18A RELA MBIP ESCO1 DDX5 CCDC88A KCNH1 SCN2A SYNE2 IQCB1 PUM3 CLINT1 PEAK1 NEXN | 3.35e-06 | 626 | 163 | 18 | int:CALM1 |
| Interaction | ZCCHC10 interactions | SRRM1 SRSF11 SNX33 PRPF40A GTF3C3 MEOX1 CEP63 RBM25 PSME3 TAF1 IK | 3.61e-06 | 236 | 163 | 11 | int:ZCCHC10 |
| Interaction | RPA4 interactions | MRE11 WDR70 PRPF40A SF1 DDX5 CEP170 RBM25 SAFB FAM120A RBM27 MKI67 SAFB2 PSME3 CLINT1 IK | 4.20e-06 | 452 | 163 | 15 | int:RPA4 |
| Interaction | NUP50 interactions | SART3 WDR70 NSD1 MORC2 PSME3IP1 PTPN2 RBM27 BRD4 PSME3 TAF1 PLEC SPEN TOR1AIP1 | 4.28e-06 | 341 | 163 | 13 | int:NUP50 |
| Interaction | PRPF3 interactions | SART3 SRRM1 TCF7L2 TRIM39 PRPF40A DDX5 TXLNA RBM25 BRD4 MKI67 UTP20 SPEN | 4.58e-06 | 291 | 163 | 12 | int:PRPF3 |
| Interaction | RAD18 interactions | CDK8 SART3 MRE11 MYH10 CAPZA1 UBA2 SAFB FAM120A BRD4 SAFB2 PSME3 ARHGEF2 IK SPEN TIMM44 | 4.80e-06 | 457 | 163 | 15 | int:RAD18 |
| Interaction | ARL16 interactions | 4.93e-06 | 83 | 163 | 7 | int:ARL16 | |
| Interaction | TNIP1 interactions | TPM4 TPR UIMC1 SRRM1 MYH10 CALD1 DSP CAPZA1 MYO18A PRPF40A DDX5 STX12 NGDN TXLNA RBM25 SAFB FAM120A NOM1 MKI67 SAFB2 UTP20 CLINT1 PLEC ARHGEF2 IK NEXN | 5.17e-06 | 1217 | 163 | 26 | int:TNIP1 |
| Interaction | CDC5L interactions | TPR MRE11 SRRM1 DDX19A DSP PPFIA1 POLR2A CAPZA1 PRPF40A DDX5 TXLNA PPP4R2 BRD4 MACF1 PSME3 CLINT1 PLEC ARHGEF2 IK SPEN NIPBL | 5.78e-06 | 855 | 163 | 21 | int:CDC5L |
| Interaction | DHX40 interactions | 6.03e-06 | 249 | 163 | 11 | int:DHX40 | |
| Interaction | CCDC8 interactions | TPR DDX19A DSP POLR2A TRIP12 SF1 DDX5 CEP170 MKI67 MACF1 UTP20 CEP131 PLEC ARHGEF2 QARS1 RAB2A TOR1AIP1 NIPBL | 6.39e-06 | 656 | 163 | 18 | int:CCDC8 |
| Interaction | PML interactions | SART3 UIMC1 TCF7L2 TCF12 CALD1 WDR70 RELA PRPF40A SF1 GTF3C3 CEP170 PSME3IP1 SAFB FAM120A BRD4 SYNE2 UTP20 WDR45B PSME3 CLINT1 IK MAPK7 | 6.49e-06 | 933 | 163 | 22 | int:PML |
| Interaction | NUMA1 interactions | MRE11 SRRM1 MYH10 TCF7L2 UBQLN4 CAPZA1 RIBC1 RNF40 RELA TRIP12 DDX5 BRD4 ATAD2B MKI67 MACF1 | 6.55e-06 | 469 | 163 | 15 | int:NUMA1 |
| Interaction | BAP1 interactions | TPM4 SART3 TPR MRE11 SRRM1 MYH10 CALD1 ANK3 FNTA DSP CAPZA1 MYO18A UBA2 AIP PRPF40A SF1 GTF3C3 DDX5 CEP170 NPHP3 FAM120A RBM27 IQCB1 MACF1 PSME3 PLEC QARS1 | 6.81e-06 | 1314 | 163 | 27 | int:BAP1 |
| Interaction | CHD4 interactions | TPR MRE11 SRRM1 MYH10 TCF7L2 TCF12 DSP KRI1 MORC2 TRIP12 PRPF40A DDX5 RBM25 SAFB PPP4R2 NOM1 BRD4 MKI67 PUM3 IK SPEN DNMT1 | 7.07e-06 | 938 | 163 | 22 | int:CHD4 |
| Interaction | NR2C2 interactions | MRE11 SRRM1 DDX19A MYH10 UBA2 KRI1 SRSF11 MCCC2 TTF1 TRIP12 PRPF40A SF1 DDX5 NGDN RBM25 SAFB FAM120A CCDC71 RBM27 MKI67 SAFB2 PLEC ARHGEF2 QARS1 TIMM44 RAB2A NIPBL DNMT1 | 7.75e-06 | 1403 | 163 | 28 | int:NR2C2 |
| Interaction | FGFBP1 interactions | UBQLN4 CENPU KRI1 TTF1 TRIP12 GTF3C3 NGDN FAM120A NOM1 MKI67 PUM3 | 8.14e-06 | 257 | 163 | 11 | int:FGFBP1 |
| Interaction | YWHAE interactions | LCA5 MYH10 CDC42BPA CALD1 PPFIA1 RAB11FIP2 CAPZA1 SNX33 TRIP12 CEP170 LNP1 NEK1 RADIL CCDC88A LATS1 KCNH2 BRD4 IRAG2 MACF1 CEP131 PEAK1 ARHGEF2 MAPK7 TIMM44 DNMT1 CCSER1 | 9.06e-06 | 1256 | 163 | 26 | int:YWHAE |
| Interaction | CALD1 interactions | TPR SRRM1 CALD1 CAPZA1 MYO18A BCL7A TRIP12 TXLNA ANKRD11 PEAK1 NEXN | 1.09e-05 | 265 | 163 | 11 | int:CALD1 |
| Interaction | CHD3 interactions | TPR MRE11 SRRM1 MYH10 DSP GPS2 KRI1 PRPF40A DDX5 NGDN RBM25 SAFB FAM120A BRD4 MKI67 PUM3 TAF1 IK TNNT1 | 1.23e-05 | 757 | 163 | 19 | int:CHD3 |
| Interaction | H3C3 interactions | UIMC1 SRRM1 WDR70 NSD1 MORC2 TRIP12 GTF3C3 BRD4 ATAD2B MKI67 PUM3 TAF1 SPEN NIPBL DNMT1 | 1.24e-05 | 495 | 163 | 15 | int:H3C3 |
| Interaction | CENPA interactions | CENPU NSD1 KRI1 MORC2 TRIP12 GTF3C3 DDX5 ANKRD11 UTP20 TAF1 TOR1AIP1 NIPBL DNMT1 | 1.26e-05 | 377 | 163 | 13 | int:CENPA |
| Interaction | SPTAN1 interactions | DDX19A CALD1 ANK3 PPFIA1 GRK5 MYO18A ZBTB1 CEP63 LATS1 FAM120A BRD4 SYNE2 IQCB1 TAF1 PLEC | 1.27e-05 | 496 | 163 | 15 | int:SPTAN1 |
| Interaction | RAB11A interactions | TPR DDX19A MYH10 CDC42BPA CALD1 PPFIA1 RAB11FIP2 KRI1 STX12 UBXN4 CCDC88A KCNH2 SYNE2 MKI67 CLINT1 PEAK1 TIMM44 RAB2A TOR1AIP1 FMNL1 | 1.30e-05 | 830 | 163 | 20 | int:RAB11A |
| Interaction | BARD1 interactions | UNC13B UIMC1 MRE11 SRRM1 POLR2A KRI1 RELA PRPF40A RBM25 CCDC88A NOM1 MKI67 | 1.31e-05 | 323 | 163 | 12 | int:BARD1 |
| Interaction | RNF113A interactions | SART3 SRRM1 DSP SRSF11 MCCC2 PRPF40A DDX5 RBM25 FAM120A PPP4R2 NOM1 MKI67 UTP20 PUM3 RERE PLEC IK QARS1 | 1.32e-05 | 692 | 163 | 18 | int:RNF113A |
| Interaction | IFI27L1 interactions | 1.42e-05 | 65 | 163 | 6 | int:IFI27L1 | |
| Interaction | H2BC21 interactions | SART3 UIMC1 MRE11 ZWILCH POLR2A UBQLN4 NSD1 RNF40 BCL7A TTF1 TRIP12 MBIP ESCO1 CCDC71 BRD4 MKI67 SAFB2 NIPBL | 1.42e-05 | 696 | 163 | 18 | int:H2BC21 |
| Interaction | TOP1 interactions | CDK8 TPR SRRM1 FNTA POLR2A SRSF11 PRPF40A GTF3C3 DDX5 RBM25 SAFB BRD4 MKI67 SAFB2 UTP20 IK TNNT1 NIPBL | 1.42e-05 | 696 | 163 | 18 | int:TOP1 |
| Interaction | NUP62 interactions | TPR DDX19A SDCCAG8 CENPU RNF40 CTIF TXLNA CCDC88A SYNE2 SAFB2 IK | 1.43e-05 | 273 | 163 | 11 | int:NUP62 |
| Interaction | TRIM37 interactions | TPM4 MYH10 TCF12 MYH13 DSP CAPZA1 MYO18A CEP63 CEP170 RBM25 RBM27 MKI67 ANKRD11 CEP131 PLEC SPEN NEXN | 1.45e-05 | 630 | 163 | 17 | int:TRIM37 |
| Interaction | HERC2 interactions | CDK8 SRRM1 MYH10 PPFIA1 NSD1 SRSF11 PRPF40A CEP170 RBM25 CCDC88A BRD4 SYNE2 MACF1 TAF1 PLEC | 1.50e-05 | 503 | 163 | 15 | int:HERC2 |
| Interaction | MYCN interactions | SART3 TPR SRRM1 MYH10 TCF12 DSP PPFIA1 GRK5 CAPZA1 CENPU SRSF11 BCL7A PRPF40A SF1 GTF3C3 DDX5 NGDN CEP170 NEK1 SAFB FAM120A NOM1 MKI67 SAFB2 PUM3 IK DNMT1 | 1.50e-05 | 1373 | 163 | 27 | int:MYCN |
| Interaction | SMU1 interactions | 1.65e-05 | 227 | 163 | 10 | int:SMU1 | |
| Interaction | SLX4 interactions | MRE11 TCF12 DSP POLR2A WDR70 MORC2 GTF3C3 DDX5 PSME3IP1 SAFB BRD4 MKI67 CLINT1 ARHGEF2 IK NIPBL | 1.70e-05 | 572 | 163 | 16 | int:SLX4 |
| Interaction | RHOD interactions | TPM4 CDC42BPA ANK3 PPFIA1 MYO18A UBXN4 CCDC88A SYNE2 MACF1 UTP20 CLINT1 PEAK1 RAB2A TOR1AIP1 FMNL1 SLC39A7 | 1.70e-05 | 572 | 163 | 16 | int:RHOD |
| Interaction | VTN interactions | 1.86e-05 | 183 | 163 | 9 | int:VTN | |
| Interaction | DCPS interactions | SART3 TPR MYH10 TRIP12 PRPF40A NGDN RBM25 MKI67 SAFB2 UTP20 PUM3 PLEC NIPBL | 2.00e-05 | 394 | 163 | 13 | int:DCPS |
| Interaction | FMNL2 interactions | CDC42BPA CALD1 GRK5 PRPF40A NPHP3 CCDC88A CLINT1 RAB2A FMNL1 | 2.02e-05 | 185 | 163 | 9 | int:FMNL2 |
| Interaction | SNRPB interactions | SART3 SRRM1 POLR2A UBA2 PRPF40A DDX5 RBM25 SAFB LATS1 BRD4 SAFB2 CC2D2A MACF1 IK QARS1 | 2.07e-05 | 517 | 163 | 15 | int:SNRPB |
| Interaction | TXLNA interactions | LCA5 CALD1 PPFIA1 MBIP STX12 MEOX1 CEP63 TXLNA KIAA1328 QARS1 | 2.31e-05 | 236 | 163 | 10 | int:TXLNA |
| Cytoband | 17p13 | 6.54e-06 | 34 | 163 | 4 | 17p13 | |
| Cytoband | 17q21 | 7.75e-05 | 63 | 163 | 4 | 17q21 | |
| GeneFamily | Myosin heavy chains | 1.41e-08 | 15 | 101 | 5 | 1098 | |
| GeneFamily | EF-hand domain containing|Plakins | 9.28e-06 | 8 | 101 | 3 | 939 | |
| GeneFamily | RNA binding motif containing | 1.92e-04 | 213 | 101 | 7 | 725 | |
| GeneFamily | Sorting nexins|PX-BAR domain containing | 1.97e-03 | 12 | 101 | 2 | 1290 | |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 9.47e-08 | 90 | 163 | 8 | M39250 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | CALD1 ANK3 SRSF11 ARHGAP6 RBM25 SYNE2 ZNF804B ANKRD11 SAFB2 PUM3 RERE | 1.49e-07 | 221 | 163 | 11 | M39222 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CCDC91 MYH10 CDC42BPA CALD1 PPFIA1 CENPU SRSF11 CEP63 CEP170 NEK1 PIEZO2 CCDC88A RBM27 PPP4R2 SYNE2 MKI67 PUM3 NIPBL | 1.57e-07 | 656 | 163 | 18 | M18979 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TPR TRIB2 FNTA CAPZA1 NSD1 UBA2 KRI1 AIP TRIP12 ZBTB1 PRPF40A SF1 DDX5 PTPN2 UBXN4 CCDC88A LATS1 RBM27 ANKRD11 AUTS2 MACF1 IK SPEN TOR1AIP1 NIPBL FMNL1 DNMT1 | 5.41e-07 | 1492 | 163 | 27 | M40023 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | MRE11 TCF12 PPFIA1 CAPZA1 CENPU SRSF11 MBIP PRPF40A ESCO1 PTPN2 RBM25 PPP4R2 ANKRD11 PUM3 NIPBL | 1.04e-06 | 523 | 163 | 15 | M12707 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | MRE11 TCF12 PPFIA1 CAPZA1 CENPU SRSF11 MBIP PRPF40A ESCO1 PTPN2 RBM25 PPP4R2 ANKRD11 PUM3 NIPBL | 1.34e-06 | 534 | 163 | 15 | MM1054 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CDK8 TCF7L2 TCF12 CDC42BPA PPFIA1 GRK5 CTIF TRIP12 CEP170 PTPN2 NEK1 ATAD2B SYNE2 MACF1 UTP20 PUM3 CLINT1 SPEN NIPBL | 1.71e-06 | 856 | 163 | 19 | M4500 |
| Coexpression | PUJANA_ATM_PCC_NETWORK | MRE11 SRRM1 MYH3 LAMB4 CAPZA1 UBA2 SRSF11 BCL7A PRPF40A SF1 DDX5 NGDN PTPN2 SAFB FAM120A KCNH1 MKI67 IRAG2 MYH15 CLINT1 TAF1 IK FMNL1 MX2 DNMT1 | 1.77e-06 | 1394 | 163 | 25 | M9585 |
| Coexpression | GABRIELY_MIR21_TARGETS | CALD1 RAB11FIP2 SRSF11 SNX30 NEK1 UBXN4 LATS1 ATAD2B SYNE2 TAF1 NIPBL | 2.11e-06 | 289 | 163 | 11 | M2196 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | TPR TCF12 CDC42BPA MYO18A CENPU SRSF11 MORC2 ADCY1 PTPN2 RBM25 UBXN4 SYNE2 SAFB2 MACF1 PUM3 CLINT1 RAB2A TOR1AIP1 | 2.27e-06 | 790 | 163 | 18 | M12490 |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP | SRRM1 MYH10 CDC42BPA ANK3 FNTA CAPZA1 UBA2 SRSF11 PRPF40A DDX5 UBXN4 AUTS2 RERE RAB2A TOR1AIP1 | 2.86e-06 | 568 | 163 | 15 | M4023 |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | SART3 SRRM1 DDX19A UBQLN4 UBA2 SRSF11 MCCC2 AIP MORC2 TRIP12 SF1 GTF3C3 NGDN PSME3IP1 RBM25 BRD4 WDR45B PSME3 RERE IK RAB2A | 7.48e-06 | 1129 | 163 | 21 | M42508 |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | SART3 SRRM1 DDX19A UBQLN4 UBA2 SRSF11 MCCC2 AIP MORC2 TRIP12 SF1 GTF3C3 NGDN PSME3IP1 RBM25 BRD4 WDR45B PSME3 RERE IK RAB2A | 1.10e-05 | 1158 | 163 | 21 | MM1338 |
| Coexpression | OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN | 1.11e-05 | 281 | 163 | 10 | M7089 | |
| Coexpression | GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN | 3.39e-05 | 197 | 163 | 8 | M3193 | |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN | 3.65e-05 | 199 | 163 | 8 | M4635 | |
| Coexpression | GSE28237_EARLY_VS_LATE_GC_BCELL_DN | 3.78e-05 | 200 | 163 | 8 | M4894 | |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2 | MYH10 RIBC1 EFHB IFT43 DNALI1 CFAP299 RADIL TXLNA CFAP45 CC2D2A IK DNAH11 | 4.14e-05 | 471 | 163 | 12 | M3062 |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 4.99e-05 | 208 | 163 | 8 | M39233 | |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_NEGATIVE | CDK8 SDCCAG8 RAB11FIP2 CEP170 CCDC88A PPP4R2 MACF1 PEAK1 MAPK7 SPEN TOR1AIP1 | 9.30e-05 | 435 | 163 | 11 | M41115 |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | TPR SRRM1 MYH3 CALD1 ANK3 POLR2A UBQLN4 SNX30 CCDC71 MKI67 SAFB2 PLEC TNNT1 | 1.21e-04 | 610 | 163 | 13 | M3854 |
| Coexpression | VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP | 1.29e-04 | 178 | 163 | 7 | M17079 | |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_DN | SRRM1 TCF12 PPFIA1 CAPZA1 SRSF11 BCL7A ZBTB1 ADCY1 DDX5 STX12 ATAD2B CLINT1 IK TOR1AIP1 | 1.38e-04 | 705 | 163 | 14 | M1410 |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 1.53e-04 | 81 | 163 | 5 | M39253 | |
| Coexpression | LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN | MRE11 SRRM1 RAB11FIP2 TATDN2 SRSF11 STX12 DNALI1 TXLNA CCDC82 MKI67 CC2D2A MACF1 RERE QARS1 SPEN | 1.64e-04 | 807 | 163 | 15 | M14594 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | CDK8 TCF7L2 TCF12 CDC42BPA PPFIA1 TRIP12 CEP170 PTPN2 ATAD2B PUM3 SPEN | 1.70e-04 | 466 | 163 | 11 | M13522 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | CALD1 GON4L BCL7A TXLNA RBM27 BRD4 ATAD2B AUTS2 TAF1 ARHGEF2 DNMT1 | 1.73e-04 | 467 | 163 | 11 | M1347 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | TPM4 TPR MRE11 ZWILCH CENPU PRPF40A CEP63 UBXN4 CCDC88A SP140L PUM3 PLEC NIPBL DNMT1 | 1.74e-04 | 721 | 163 | 14 | M10237 |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 1.78e-04 | 250 | 163 | 8 | M11318 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | TPR SRRM1 MYH3 CALD1 ANK3 POLR2A UBQLN4 SNX30 CCDC71 MKI67 SAFB2 PLEC TNNT1 | 2.24e-04 | 650 | 163 | 13 | MM1042 |
| Coexpression | GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP | 2.34e-04 | 196 | 163 | 7 | M3243 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | CALD1 GON4L BCL7A TXLNA RBM27 BRD4 ATAD2B AUTS2 TAF1 ARHGEF2 DNMT1 | 2.35e-04 | 484 | 163 | 11 | MM999 |
| Coexpression | GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP | 2.49e-04 | 198 | 163 | 7 | M4240 | |
| Coexpression | LU_AGING_BRAIN_UP | 2.52e-04 | 263 | 163 | 8 | M5547 | |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_DN | 2.57e-04 | 199 | 163 | 7 | M9418 | |
| Coexpression | GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN | 2.57e-04 | 199 | 163 | 7 | M7524 | |
| Coexpression | GSE21546_UNSTIM_VS_ANTI_CD3_STIM_DP_THYMOCYTES_DN | 2.57e-04 | 199 | 163 | 7 | M7549 | |
| Coexpression | GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN | 2.57e-04 | 199 | 163 | 7 | M6060 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 2.57e-04 | 199 | 163 | 7 | M5893 | |
| Coexpression | GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN | 2.57e-04 | 199 | 163 | 7 | M5340 | |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN | 2.57e-04 | 199 | 163 | 7 | M5240 | |
| Coexpression | GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN | 2.57e-04 | 199 | 163 | 7 | M9178 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_LUNG_DN | 2.57e-04 | 199 | 163 | 7 | M4350 | |
| Coexpression | GSE26488_CTRL_VS_PEPTIDE_INJECTION_HDAC7_DELTAP_TG_OT2_THYMOCYTE_DN | 2.65e-04 | 200 | 163 | 7 | M8199 | |
| Coexpression | GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_UP | 2.65e-04 | 200 | 163 | 7 | M4590 | |
| Coexpression | GSE27786_LIN_NEG_VS_NKCELL_DN | 2.65e-04 | 200 | 163 | 7 | M4784 | |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN | 2.65e-04 | 200 | 163 | 7 | M4979 | |
| Coexpression | GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP | 2.65e-04 | 200 | 163 | 7 | M7911 | |
| Coexpression | GSE360_L_DONOVANI_VS_L_MAJOR_MAC_UP | 2.65e-04 | 200 | 163 | 7 | M5231 | |
| Coexpression | GSE17721_0.5H_VS_8H_PAM3CSK4_BMDC_DN | 2.65e-04 | 200 | 163 | 7 | M4111 | |
| Coexpression | GSE20715_0H_VS_6H_OZONE_LUNG_UP | 2.65e-04 | 200 | 163 | 7 | M4360 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | SART3 MRE11 CAPZA1 TATDN2 UBA2 SRSF11 BCL7A TTF1 NGDN PTPN2 MKI67 UTP20 PUM3 DNMT1 | 3.02e-04 | 761 | 163 | 14 | M11961 |
| Coexpression | MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN | 3.15e-04 | 272 | 163 | 8 | M15123 | |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_CILIARY_BODY_ENDOTHELIAL_CELLS | 4.07e-04 | 356 | 163 | 9 | M43609 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CDK8 TPM4 TPR SRRM1 ZWILCH MYH10 TCF12 RIBC1 CENPU NSD1 SRSF11 FANCM TTF1 PRPF40A RBM25 CCDC88A RBM27 BRD4 ATAD2B SYNE2 IQCB1 KIAA1328 MKI67 AUTS2 MACF1 UTP20 NIPBL DNMT1 CCSER1 | 7.14e-08 | 1257 | 161 | 29 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | CDK8 TPM4 TPR SRRM1 ZWILCH MYH10 TCF12 RIBC1 CENPU NSD1 SRSF11 FANCM TTF1 PRPF40A RBM25 CCDC88A RBM27 BRD4 ATAD2B SYNE2 IQCB1 KIAA1328 MKI67 AUTS2 MACF1 UTP20 NIPBL DNMT1 CCSER1 | 1.56e-06 | 1459 | 161 | 29 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | SART3 DDX19A TCF7L2 PPFIA1 GPS2 GON4L TRIM39 CEP63 NEK1 SAFB CCDC88A LATS1 SYNE2 MKI67 SAFB2 CC2D2A RERE CCDC171 RAB2A NIPBL | 5.12e-06 | 831 | 161 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | SRRM1 MYH10 POLR2A UBA2 SRSF11 ZBTB1 PRPF40A CEP170 PTPN2 NEK1 FAM120A ATAD2B SYNE2 MKI67 MACF1 TAF1 NIPBL | 6.17e-06 | 629 | 161 | 17 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | TPR SRRM1 POLR2A UBA2 SRSF11 FANCM ZBTB1 CEP170 PTPN2 NEK1 FAM120A PPP4R2 ATAD2B MKI67 MACF1 CLINT1 | 6.42e-06 | 564 | 161 | 16 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | TPR MYH10 CALD1 PRPF40A RBM25 CCDC88A ATAD2B MKI67 MACF1 PEAK1 NIPBL | 1.79e-05 | 298 | 161 | 11 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | DDX19A TCF7L2 PPFIA1 MYO18A GON4L TRIM39 CCDC88A LATS1 ATAD2B SYNE2 MKI67 SAFB2 CC2D2A MACF1 RERE IK RAB2A NIPBL | 2.74e-05 | 780 | 161 | 18 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | TPM4 SART3 FANCM ZBTB1 PRPF40A ESCO1 CEP63 RBM25 SAFB RBM27 PPP4R2 ANKRD11 NIPBL DNMT1 | 5.63e-05 | 532 | 161 | 14 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | TPR MYH10 SRSF11 ZBTB1 PRPF40A ATAD2B MKI67 MACF1 PEAK1 ARHGEF2 NIPBL FMNL1 | 1.17e-04 | 432 | 161 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | CDK8 UNC13B TPR LCA5 ZWILCH TCF12 CENPU CTIF FANCM TTF1 MBIP PRPF40A RBM25 CCDC88A KCNH2 ATAD2B SYNE2 MKI67 MACF1 NIPBL | 1.58e-04 | 1060 | 161 | 20 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | UIMC1 TCF7L2 TRIB2 GRK5 GPS2 SNX33 IFT43 NPHP3 CCDC88A LATS1 KCNH2 ATAD2B SYNE2 MKI67 MACF1 PEAK1 CCDC171 NIPBL CCSER1 | 1.76e-04 | 985 | 161 | 19 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | TPR LCA5 SRRM1 CDC42BPA TRIP12 PRPF40A UBXN4 FAM120A BRD4 SYNE2 ANKRD11 CLINT1 NIPBL | 5.27e-13 | 199 | 163 | 13 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | CCDC91 LCA5 CDC42BPA TRIP12 PRPF40A UBXN4 FAM120A BRD4 SYNE2 ANKRD11 CLINT1 NIPBL | 1.09e-11 | 199 | 163 | 12 | 61b1ed2db71b96157b92b7535d1955a4033098da |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | CDC42BPA CALD1 UBXN4 CCDC88A FAM120A RBM27 BRD4 SYNE2 ANKRD11 CLINT1 NEXN NIPBL | 1.09e-11 | 199 | 163 | 12 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | TPR SRSF11 TRIP12 SF1 DDX5 RBM25 ATAD2B SYNE2 ANKRD11 MACF1 NIPBL MX2 | 1.15e-11 | 200 | 163 | 12 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TPR SRRM1 SRSF11 PRPF40A RBM25 UBXN4 RBM27 BRD4 SYNE2 ANKRD11 NIPBL | 1.11e-10 | 188 | 163 | 11 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | POLR2A KRI1 SRSF11 TTF1 PRPF40A RBM25 CCDC88A SAFB2 PUM3 NEXN DNMT1 | 1.84e-10 | 197 | 163 | 11 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | SRRM1 CDC42BPA PRPF40A CEP170 RBM25 UBXN4 CCDC88A BRD4 SYNE2 ANKRD11 NIPBL | 1.94e-10 | 198 | 163 | 11 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | SRRM1 CALD1 PRPF40A UBXN4 CCDC88A FAM120A RBM27 BRD4 SYNE2 ANKRD11 NIPBL | 2.05e-10 | 199 | 163 | 11 | 19674e1eaeb51e4196d847cb62aa437c852951d3 |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | SRRM1 CDC42BPA PRPF40A RBM25 UBXN4 FAM120A RBM27 BRD4 SYNE2 ANKRD11 CLINT1 | 2.05e-10 | 199 | 163 | 11 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | TPR SRRM1 CALD1 RBM25 UBXN4 CCDC88A FAM120A BRD4 SYNE2 ANKRD11 NIPBL | 2.05e-10 | 199 | 163 | 11 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 2.21e-09 | 138 | 163 | 9 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | SRRM1 TRIP12 PRPF40A RBM25 UBXN4 FAM120A BRD4 SYNE2 ANKRD11 NIPBL | 3.50e-09 | 199 | 163 | 10 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.67e-09 | 200 | 163 | 10 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-08 | 178 | 163 | 9 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-08 | 187 | 163 | 9 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 5.37e-08 | 199 | 163 | 9 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-07 | 184 | 163 | 8 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.98e-07 | 189 | 163 | 8 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 5.61e-07 | 192 | 163 | 8 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 5.61e-07 | 192 | 163 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.81e-07 | 197 | 163 | 8 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 7.08e-07 | 198 | 163 | 8 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.35e-07 | 199 | 163 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-06 | 182 | 163 | 7 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-06 | 185 | 163 | 7 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | saliva-Severe-critical_progression_d28-40|saliva / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.70e-06 | 186 | 163 | 7 | 0095560ca776b01aa473ad4d6015ed78fc93ff51 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.70e-06 | 186 | 163 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | moderate-Epithelial-Ciliated-diff|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.78e-06 | 191 | 163 | 7 | 6cdc6a0c0a1ce5a1ef550832319847f62e718975 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-06 | 191 | 163 | 7 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.78e-06 | 191 | 163 | 7 | 3e84c453e8a151c42808fe2935f1d732e180008c | |
| ToppCell | moderate-Epithelial-Ciliated-diff|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.78e-06 | 191 | 163 | 7 | b1bb27aab6ec651b45d5eea0a6b61a1da0fc6204 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-06 | 191 | 163 | 7 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-06 | 191 | 163 | 7 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 7.02e-06 | 192 | 163 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.26e-06 | 193 | 163 | 7 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | ASK440-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.51e-06 | 194 | 163 | 7 | c84a7fa94fb06e08aae04db56c8c313b0afde1d7 | |
| ToppCell | ASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.51e-06 | 194 | 163 | 7 | 5aeb44657ab6f61b1abf98af28d3397d8e44c1aa | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.76e-06 | 195 | 163 | 7 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.76e-06 | 195 | 163 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.76e-06 | 195 | 163 | 7 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 8.03e-06 | 196 | 163 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.30e-06 | 197 | 163 | 7 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | PND01-Mesenchymal|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.30e-06 | 197 | 163 | 7 | 292b8cc3dafddf5d323fe4e3d3ea5ac61e6ce027 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 8.30e-06 | 197 | 163 | 7 | e666f6580e9a20b5e550f02125706db17eec8510 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.30e-06 | 197 | 163 | 7 | 106b0f9a0425facc634feb7498c9ba2c55edfbf8 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 9.15e-06 | 200 | 163 | 7 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.39e-05 | 156 | 163 | 6 | 203ef22eb76bd2b829b027c30af0557080f4006c | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-DZ_GC_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.96e-05 | 162 | 163 | 6 | 3e15b3e97a2ade86d0cb0ab15fccb9a2e2e27dd4 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.06e-05 | 163 | 163 | 6 | 360cd65decda24853124f33a174f5224d7f3ce23 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.06e-05 | 163 | 163 | 6 | b59d9b4f7c9f4e5e2c7783a49a96729dae3a81e5 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-05 | 169 | 163 | 6 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.27e-05 | 173 | 163 | 6 | b7e0193fd4983cb38d1bee441f608f73ee8743b9 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-05 | 176 | 163 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-GC_B_(II)|lymph-node_spleen / Manually curated celltypes from each tissue | 4.70e-05 | 176 | 163 | 6 | 5788dd5b23ebb52f19d3b5bdbcfe25dee349cf77 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-05 | 177 | 163 | 6 | e8bb4f8ecd5e283efec966b9fc2040a6152d5551 | |
| ToppCell | control-Others-CD34+_GATA2+_cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.00e-05 | 178 | 163 | 6 | 2120bd3e099b0b271bf079db9827a2f3eee2f909 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-05 | 178 | 163 | 6 | b1db59344c074c7c80169fc2c5cd5fc89f3fe463 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-05 | 178 | 163 | 6 | 579cdc14f28b459e200ae2102e0bd4df8a2c0dcb | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.16e-05 | 179 | 163 | 6 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic-hematopoietic_progenitor|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.33e-05 | 180 | 163 | 6 | f598bb9df0d784120847fada2d9a2a88b8b68cd1 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.33e-05 | 180 | 163 | 6 | b4fa047f271c7b56940bdc85c912f50aa5b5ca82 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.49e-05 | 181 | 163 | 6 | 2b9b460239d67fd480cee60820cdb306109d3567 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.49e-05 | 181 | 163 | 6 | 2a1aa4a0ec7bc367857beaff543135e4345c835b | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.66e-05 | 182 | 163 | 6 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 5.84e-05 | 183 | 163 | 6 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| ToppCell | LV-07._Pericyte|World / Chamber and Cluster_Paper | 5.84e-05 | 183 | 163 | 6 | 273db6a3b00a93ca852498471187b642b5368185 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.02e-05 | 184 | 163 | 6 | ba65e3972b2b8d825a2c1a9d03d092cc1afad073 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.02e-05 | 184 | 163 | 6 | 2df903924df9cb71039159416bcbe6a6614e21fe | |
| ToppCell | COVID-19_Moderate-HSPC|World / disease group, cell group and cell class | 6.02e-05 | 184 | 163 | 6 | ccc93babe1fcdeb66b78e1d8414357877a7c45bd | |
| ToppCell | COVID-19_Moderate-HSPC|COVID-19_Moderate / disease group, cell group and cell class | 6.20e-05 | 185 | 163 | 6 | cacc6ab5f26f6c803894567fb838ea06eaa7efe5 | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell|TCGA-Uvea / Sample_Type by Project: Shred V9 | 6.39e-05 | 186 | 163 | 6 | e8580a2093eb7e50aad55ec7fada850d2fed8ae1 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.39e-05 | 186 | 163 | 6 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.39e-05 | 186 | 163 | 6 | 722da08cd978249a19855fd3ec8ddda780c99d83 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_LZ|B_lymphocytes / Location, Cell class and cell subclass | 6.58e-05 | 187 | 163 | 6 | 457eb3791a8c5458d81833e0701ac5a9bfdee2bf | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 6.58e-05 | 187 | 163 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | RV-07._Pericyte|World / Chamber and Cluster_Paper | 6.58e-05 | 187 | 163 | 6 | dc274d6bbda619a2c914d84e2b4069cfef1739d1 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.58e-05 | 187 | 163 | 6 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 6.77e-05 | 188 | 163 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 6.77e-05 | 188 | 163 | 6 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | E12.5-Mesenchymal|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.77e-05 | 188 | 163 | 6 | 9778dadc2bd7ded3a723e717d1c8cd3160e99c6c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 6.77e-05 | 188 | 163 | 6 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 6.77e-05 | 188 | 163 | 6 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.91e-05 | 60 | 163 | 4 | 28415d543aaccc74d19e1bb92b7e6fa94f97f8f2 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.91e-05 | 60 | 163 | 4 | 71eba0fbef11cfc2b1c525d5f051530750e4fce9 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.98e-05 | 189 | 163 | 6 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-hematopoietic_progenitor-common_myeloid_progenitor|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.98e-05 | 189 | 163 | 6 | 56156325cc36b1329bf483f81bb74f371ef15e20 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 6.98e-05 | 189 | 163 | 6 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.18e-05 | 190 | 163 | 6 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.18e-05 | 190 | 163 | 6 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.18e-05 | 190 | 163 | 6 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.18e-05 | 190 | 163 | 6 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_LZ|B_lymphocytes / Location, Cell class and cell subclass | 7.18e-05 | 190 | 163 | 6 | c5c80a6b9087821a2e07250fa90bcd3505f103b6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.39e-05 | 191 | 163 | 6 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.39e-05 | 191 | 163 | 6 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 7.39e-05 | 191 | 163 | 6 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.39e-05 | 191 | 163 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | normal_Lung-Epithelial_cells-Ciliated|normal_Lung / Location, Cell class and cell subclass | 7.61e-05 | 192 | 163 | 6 | 097a13121820ab4e5cd2365600efccf5ea4ce8c3 | |
| ToppCell | PND07|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.61e-05 | 192 | 163 | 6 | 8171a60df481195c39a7f740effcae8e4deb6ca7 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.61e-05 | 192 | 163 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | ASK452-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.83e-05 | 193 | 163 | 6 | c0d10075862ac878aa05fc49c8b73e470783bf16 | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | SART3 TPR MYH10 CDC42BPA CALD1 ANK3 PRPF40A NEK1 RBM25 UBXN4 ANKRD11 SPEN | 6.67e-09 | 179 | 163 | 12 | 4585_DN |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | SART3 TPR MYH10 CDC42BPA TTF1 PRPF40A RBM25 UBXN4 BRD4 ANKRD11 SPEN | 6.32e-08 | 177 | 163 | 11 | 985_DN |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | SART3 TPR MYH10 CDC42BPA CALD1 PRPF40A NEK1 RBM25 CCDC88A ANKRD11 SPEN | 6.70e-08 | 178 | 163 | 11 | 3998_DN |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | TPR CDC42BPA CALD1 BCL7A SF1 RBM25 UBXN4 CCDC88A UTP20 PLEC SPEN | 1.11e-07 | 187 | 163 | 11 | 4302_DN |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | SART3 MYH10 TCF7L2 CDC42BPA PRPF40A SF1 NEK1 RBM25 UBXN4 SPEN | 1.07e-06 | 188 | 163 | 10 | 6735_DN |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; PC3; HG-U133A | DDX19A ZWILCH ANK3 AIP PRPF40A SAFB PLEC ARHGEF2 TNNT1 TIMM44 | 1.56e-06 | 196 | 163 | 10 | 1927_DN |
| Drug | MS-275; Down 200; 10uM; PC3; HT_HG-U133A | 9.22e-06 | 189 | 163 | 9 | 7074_DN | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A | 9.62e-06 | 190 | 163 | 9 | 4307_DN | |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; HL60; HG-U133A | 1.05e-05 | 192 | 163 | 9 | 1599_DN | |
| Drug | Ethoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A | 1.09e-05 | 193 | 163 | 9 | 4321_DN | |
| Drug | Homocysteine | 1.19e-05 | 195 | 163 | 9 | ctd:D006710 | |
| Drug | Oxethazaine [126-27-2]; Down 200; 8.6uM; HL60; HG-U133A | 1.19e-05 | 195 | 163 | 9 | 1984_DN | |
| Drug | AC1L9MBG | 1.21e-05 | 42 | 163 | 5 | CID000448761 | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; HL60; HG-U133A | 1.23e-05 | 196 | 163 | 9 | 1593_DN | |
| Drug | Moroxidine hydrochloride [3160-91-6]; Down 200; 19.2uM; PC3; HG-U133A | 1.29e-05 | 197 | 163 | 9 | 1944_DN | |
| Drug | Trimethoprim [738-70-5]; Down 200; 13.8uM; HL60; HT_HG-U133A | 1.34e-05 | 198 | 163 | 9 | 2345_DN | |
| Drug | Methimazole [60-56-0]; Down 200; 35uM; HL60; HT_HG-U133A | 1.34e-05 | 198 | 163 | 9 | 2570_DN | |
| Drug | Diflunisal [22494-42-4]; Down 200; 16uM; PC3; HG-U133A | 1.34e-05 | 198 | 163 | 9 | 1908_DN | |
| Drug | LY97241 | 2.93e-05 | 9 | 163 | 3 | CID000175064 | |
| Drug | phenytoin | 2.97e-05 | 219 | 163 | 9 | CID000001775 | |
| Drug | WAY-123,398 | 4.17e-05 | 10 | 163 | 3 | CID000132160 | |
| Drug | desmethylastemizole | 5.09e-05 | 2 | 163 | 2 | ctd:C040463 | |
| Drug | Benperidol | 5.09e-05 | 2 | 163 | 2 | ctd:D001544 | |
| Drug | purealin | 5.97e-05 | 58 | 163 | 5 | CID006419303 | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 7.26e-05 | 191 | 163 | 8 | 4303_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | 7.26e-05 | 191 | 163 | 8 | 4283_DN | |
| Drug | 0297417-0002B [362658-29-5]; Down 200; 10uM; MCF7; HT_HG-U133A | 7.26e-05 | 191 | 163 | 8 | 6900_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 7.26e-05 | 191 | 163 | 8 | 1059_DN | |
| Drug | clenbuterol | 7.50e-05 | 142 | 163 | 7 | CID000002783 | |
| Drug | Astemizole [68844-77-9]; Down 200; 8.8uM; HL60; HG-U133A | CDC42BPA RAB11FIP2 SAFB CCDC88A MKI67 ARHGEF2 TOR1AIP1 CACNA2D3 | 7.53e-05 | 192 | 163 | 8 | 1365_DN |
| Drug | farnesene | 7.56e-05 | 12 | 163 | 3 | CID000010407 | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A | 7.81e-05 | 193 | 163 | 8 | 1647_UP | |
| Drug | MS-275; Down 200; 10uM; PC3; HT_HG-U133A | 7.81e-05 | 193 | 163 | 8 | 7084_DN | |
| Drug | Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; PC3; HT_HG-U133A | 8.10e-05 | 194 | 163 | 8 | 4308_DN | |
| Drug | Azlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; HL60; HT_HG-U133A | 8.40e-05 | 195 | 163 | 8 | 2727_DN | |
| Drug | Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; HL60; HT_HG-U133A | 8.40e-05 | 195 | 163 | 8 | 6159_DN | |
| Drug | monastrol; Up 200; 100uM; MCF7; HG-U133A | 8.70e-05 | 196 | 163 | 8 | 627_UP | |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | 8.70e-05 | 196 | 163 | 8 | 2667_DN | |
| Drug | 16, 16-dimethylprostaglandin E2 methyl acetate solution; Down 200; 10uM; PC3; HT_HG-U133A | 8.70e-05 | 196 | 163 | 8 | 6562_DN | |
| Drug | Testosterone propionate [57-85-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 8.70e-05 | 196 | 163 | 8 | 5636_DN | |
| Drug | benz(a)anthracene | TPR TCF7L2 TRIB2 TCF12 ANK3 NSD1 GON4L SRSF11 RELA EFHB PLEKHD1 MBIP DDX5 TXLNA CCDC82 ATAD2B SYNE2 MKI67 IRAG2 TAF1 DMP1 MX2 | 8.83e-05 | 1251 | 163 | 22 | ctd:C030935 |
| Drug | dofetilide | 8.89e-05 | 63 | 163 | 5 | CID000071329 | |
| Drug | Sulfameter [651-06-9]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 9.01e-05 | 197 | 163 | 8 | 6212_DN | |
| Drug | U-62066 [87151-85-7]; Down 200; 1uM; PC3; HT_HG-U133A | 9.01e-05 | 197 | 163 | 8 | 4553_DN | |
| Drug | Pergolide mesylate [66104-23-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 9.34e-05 | 198 | 163 | 8 | 7031_DN | |
| Drug | PHA-00851261E [724719-49-7]; Up 200; 1uM; PC3; HT_HG-U133A | 9.34e-05 | 198 | 163 | 8 | 4333_UP | |
| Drug | Naringin hydrate [11032-30-7]; Down 200; 6.6uM; HL60; HT_HG-U133A | 9.34e-05 | 198 | 163 | 8 | 2425_DN | |
| Drug | Thalidomide [50-35-1]; Down 200; 15.4uM; HL60; HG-U133A | 9.34e-05 | 198 | 163 | 8 | 1411_DN | |
| Drug | Ricinine [524-40-3]; Up 200; 24.4uM; MCF7; HT_HG-U133A | 9.34e-05 | 198 | 163 | 8 | 6206_UP | |
| Drug | Artemisinin [63968-64-9]; Down 200; 14.2uM; PC3; HT_HG-U133A | 9.67e-05 | 199 | 163 | 8 | 7247_DN | |
| Drug | Cephapirin sodium salt [24356-60-3]; Up 200; 9uM; MCF7; HT_HG-U133A | 9.67e-05 | 199 | 163 | 8 | 6790_UP | |
| Drug | 2-phenylindole | 9.77e-05 | 13 | 163 | 3 | CID000013698 | |
| Drug | 4-(3,6-dimethylheptan-3-yl)phenol | 9.93e-05 | 34 | 163 | 4 | CID010633340 | |
| Drug | 4-chloroaniline | 1.07e-04 | 202 | 163 | 8 | CID000007812 | |
| Drug | methanesulfonanilide | 1.24e-04 | 14 | 163 | 3 | CID000070970 | |
| Drug | Dofetilide | 1.52e-04 | 3 | 163 | 2 | DB00204 | |
| Drug | pamoic acid | 1.52e-04 | 3 | 163 | 2 | CID000008546 | |
| Drug | ersentilide | 1.52e-04 | 3 | 163 | 2 | CID000130400 | |
| Drug | perilla ketone | 1.52e-04 | 3 | 163 | 2 | CID000068381 | |
| Drug | NSC98536 | 1.54e-04 | 15 | 163 | 3 | CID000004080 | |
| Drug | carvedilol | 1.64e-04 | 161 | 163 | 7 | CID000002585 | |
| Disease | Ciliopathies | 9.93e-09 | 110 | 161 | 9 | C4277690 | |
| Disease | AUTISM, SUSCEPTIBILITY TO, 15 | 8.75e-06 | 8 | 161 | 3 | C2677504 | |
| Disease | Neurodevelopmental Disorders | 1.24e-05 | 93 | 161 | 6 | C1535926 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.86e-05 | 10 | 161 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.86e-05 | 10 | 161 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.86e-05 | 10 | 161 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.86e-05 | 10 | 161 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.86e-05 | 10 | 161 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.86e-05 | 10 | 161 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.86e-05 | 10 | 161 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.86e-05 | 10 | 161 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | Colonic Neoplasms | 2.11e-05 | 152 | 161 | 7 | C0009375 | |
| Disease | Malignant tumor of colon | 2.81e-05 | 159 | 161 | 7 | C0007102 | |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 3.38e-05 | 12 | 161 | 3 | C0403553 | |
| Disease | distal myopathy (implicated_via_orthology) | 3.38e-05 | 12 | 161 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 3.38e-05 | 12 | 161 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 4.38e-05 | 13 | 161 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 6.91e-05 | 15 | 161 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | pain | 1.06e-04 | 196 | 161 | 7 | EFO_0003843 | |
| Disease | unipolar depression, bipolar disorder | 2.23e-04 | 156 | 161 | 6 | EFO_0003761, MONDO_0004985 | |
| Disease | Malignant neoplasm of breast | TPM4 MRE11 RELA CTIF PLEKHD1 STX12 KCNH1 ANKEF1 SYNE2 MKI67 MACF1 UTP20 SPEN TOR1AIP1 NIPBL DNMT1 | 2.75e-04 | 1074 | 161 | 16 | C0006142 |
| Disease | Congenital muscular hypertrophy-cerebral syndrome | 2.93e-04 | 5 | 161 | 2 | C1802395 | |
| Disease | Cornelia de Lange Syndrome 3 | 2.93e-04 | 5 | 161 | 2 | C1853099 | |
| Disease | Cornelia de Lange Syndrome 1 | 2.93e-04 | 5 | 161 | 2 | C4551851 | |
| Disease | red blood cell density measurement | SRRM1 TCF7L2 TRIB2 RAB11FIP2 CTIF SNX33 BCL7A SNX30 PTPN2 SP140L KCNH1 BRD4 CC2D2A PLEC | 3.50e-04 | 880 | 161 | 14 | EFO_0007978 |
| Disease | nephronophthisis (is_implicated_in) | 4.37e-04 | 6 | 161 | 2 | DOID:12712 (is_implicated_in) | |
| Disease | De Lange syndrome | 4.37e-04 | 6 | 161 | 2 | cv:C0270972 | |
| Disease | retinopathy, type 2 diabetes mellitus | 4.37e-04 | 6 | 161 | 2 | EFO_0003839, MONDO_0005148 | |
| Disease | ARTHROGRYPOSIS, DISTAL, TYPE 2B | 4.37e-04 | 6 | 161 | 2 | C1834523 | |
| Disease | perivascular space measurement | 5.81e-04 | 30 | 161 | 3 | EFO_0803382 | |
| Disease | Senior-Loken syndrome (is_implicated_in) | 6.10e-04 | 7 | 161 | 2 | DOID:0050576 (is_implicated_in) | |
| Disease | Renal dysplasia and retinal aplasia | 6.10e-04 | 7 | 161 | 2 | cv:C0403553 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 6.24e-04 | 71 | 161 | 4 | DOID:0050700 (implicated_via_orthology) | |
| Disease | cancer (implicated_via_orthology) | 7.01e-04 | 268 | 161 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | heart conduction disease (implicated_via_orthology) | 7.04e-04 | 32 | 161 | 3 | DOID:10273 (implicated_via_orthology) | |
| Disease | Cornelia De Lange Syndrome | 8.11e-04 | 8 | 161 | 2 | C0270972 | |
| Disease | Intellectual Disability | 8.16e-04 | 447 | 161 | 9 | C3714756 | |
| Disease | Thyroid Gland Follicular Adenoma | 9.18e-04 | 35 | 161 | 3 | C0151468 | |
| Disease | Distal arthrogryposis | 1.04e-03 | 9 | 161 | 2 | cv:C0265213 | |
| Disease | Epilepsy, Cryptogenic | 1.07e-03 | 82 | 161 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 1.07e-03 | 82 | 161 | 4 | C0751111 | |
| Disease | Aura | 1.07e-03 | 82 | 161 | 4 | C0236018 | |
| Disease | Thyroid Neoplasm | 1.08e-03 | 37 | 161 | 3 | C0040136 | |
| Disease | Disorder of eye | 1.12e-03 | 212 | 161 | 6 | C0015397 | |
| Disease | Abnormality of refraction | CCDC91 TCF7L2 ANK3 DDX5 CFAP299 PPP4R2 SCN2A AUTS2 RERE PEAK1 TOR1AIP1 | 1.22e-03 | 673 | 161 | 11 | HP_0000539 |
| Disease | Meckel-Gruber syndrome | 1.29e-03 | 10 | 161 | 2 | cv:C0265215 | |
| Disease | long QT syndrome (implicated_via_orthology) | 1.29e-03 | 10 | 161 | 2 | DOID:2843 (implicated_via_orthology) | |
| Disease | body weight | UNC13B CCDC91 TCF7L2 WDR70 GON4L RET BCL7A TRIP12 KCNH2 KIAA1328 AUTS2 PRKG2 DMP1 CCDC171 NIPBL CCSER1 | 1.52e-03 | 1261 | 161 | 16 | EFO_0004338 |
| Disease | liver fat measurement | 1.68e-03 | 43 | 161 | 3 | EFO_0010821 | |
| Disease | biological sex | 1.70e-03 | 230 | 161 | 6 | PATO_0000047 | |
| Disease | Thyroid carcinoma | 1.79e-03 | 44 | 161 | 3 | C0549473 | |
| Disease | Adenocarcinoma of large intestine | 1.92e-03 | 96 | 161 | 4 | C1319315 | |
| Disease | myopathy (implicated_via_orthology) | 2.30e-03 | 48 | 161 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 2.58e-03 | 14 | 161 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | femoral neck bone geometry | 2.58e-03 | 14 | 161 | 2 | EFO_0004511 | |
| Disease | sitting height ratio | 2.74e-03 | 51 | 161 | 3 | EFO_0007118 | |
| Disease | cigarettes per day measurement | 2.89e-03 | 438 | 161 | 8 | EFO_0006525 | |
| Disease | Generalized hypotonia | 2.97e-03 | 15 | 161 | 2 | C1858120 | |
| Disease | Carcinoma of Endocrine Gland | 2.97e-03 | 15 | 161 | 2 | C1704374 | |
| Disease | Epilepsy | 3.05e-03 | 109 | 161 | 4 | C0014544 | |
| Disease | risk-taking behaviour | DDX19A TCF7L2 SDCCAG8 UBQLN4 TRIM39 CTIF ATAD2B KIAA1328 AUTS2 CC2D2A CCDC171 | 3.26e-03 | 764 | 161 | 11 | EFO_0008579 |
| Disease | brain measurement, neuroimaging measurement | 3.34e-03 | 550 | 161 | 9 | EFO_0004346, EFO_0004464 | |
| Disease | factor VII measurement | 3.40e-03 | 55 | 161 | 3 | EFO_0004619 | |
| Disease | optic cup area measurement | 3.58e-03 | 56 | 161 | 3 | EFO_0006940 | |
| Disease | hypertrophic cardiomyopathy (is_marker_for) | 3.81e-03 | 17 | 161 | 2 | DOID:11984 (is_marker_for) | |
| Disease | MHPG measurement, 5-HIAA measurement | 3.81e-03 | 17 | 161 | 2 | EFO_0005132, EFO_0005133 | |
| Disease | Polydactyly | 3.93e-03 | 117 | 161 | 4 | C0152427 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 3.96e-03 | 364 | 161 | 7 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | neuroticism measurement, cognitive function measurement | 4.03e-03 | 566 | 161 | 9 | EFO_0007660, EFO_0008354 | |
| Disease | brain infarction | 4.27e-03 | 18 | 161 | 2 | EFO_0004277 | |
| Disease | Feeding difficulties | 4.27e-03 | 18 | 161 | 2 | C0232466 | |
| Disease | Meckel syndrome type 1 | 4.27e-03 | 18 | 161 | 2 | C3714506 | |
| Disease | health study participation | 4.42e-03 | 195 | 161 | 5 | EFO_0010130 | |
| Disease | cutaneous melanoma | 4.42e-03 | 121 | 161 | 4 | EFO_0000389 | |
| Disease | metabolonic lactone sulfate measurement | 4.76e-03 | 19 | 161 | 2 | EFO_0800659 | |
| Disease | methadone dose measurement | 4.76e-03 | 62 | 161 | 3 | EFO_0007907 | |
| Disease | neuroimaging measurement, brain volume measurement | 4.96e-03 | 286 | 161 | 6 | EFO_0004346, EFO_0006930 | |
| Disease | body fat distribution | 5.12e-03 | 202 | 161 | 5 | EFO_0004341 | |
| Disease | CCL5 measurement | 5.21e-03 | 64 | 161 | 3 | EFO_0005117 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KDKAFREAERRIREC | 136 | Q495M9 | |
| RKKRRYSALEVDEEA | 86 | Q15361 | |
| RVAQSESKRRKAEEI | 801 | Q5SW79 | |
| RESKKIADEDALRRI | 716 | O75150 | |
| IKDTNKDISRSFREE | 721 | Q6UB99 | |
| RRRLKEKDEVAVETT | 351 | O43310 | |
| EDKDQDEKRRRVTSR | 196 | P26358 | |
| QFRRAAREKEEREKA | 1226 | O60885 | |
| DRVSDEEKVRIAAKF | 6 | P52907 | |
| RIDRSRELASKTREK | 11 | Q92974 | |
| EERLRKEFEATTLRV | 266 | Q6TFL3 | |
| KEFEATTLRVRKLEE | 271 | Q6TFL3 | |
| EEEKRRRKEQSDLTT | 96 | Q13227 | |
| SIEESDTRRKVKSAE | 141 | Q71F23 | |
| EKVSREKTIADAEER | 3146 | Q96DT5 | |
| FKAASKEIRRAERIA | 296 | Q9NU02 | |
| KITRSLTEDFEREKE | 126 | Q9C0I3 | |
| ASQEREAKETERKRR | 116 | O94850 | |
| ARIRQKDEEDKARFR | 311 | O00170 | |
| RREVKKEEGEAFARE | 126 | P61019 | |
| EDKRDLISREISKFR | 271 | P49756 | |
| SESSERRTREKKRED | 126 | Q9P2N5 | |
| KRRTQGEITKEREDE | 2106 | Q96L73 | |
| FVIDEKTAEIRLKRA | 291 | Q9Y5E4 | |
| ESALRKRIREDRKAT | 346 | P17706 | |
| SKKDTEVRRRELLES | 471 | Q15397 | |
| ARKERTAFTKEQLRE | 171 | P50221 | |
| EEARRRIEEEKKAFA | 331 | Q0ZGT2 | |
| RFELRKRSDVEELAA | 156 | Q96JH8 | |
| AFDREALTRERIKEA | 366 | Q13164 | |
| EIKSRKKVEEERSSR | 146 | A1A4G5 | |
| KFSLRRAVSVKQREE | 111 | Q8TD91 | |
| TIDDTISKFRRKDRE | 211 | Q14677 | |
| TGEERRKISEEAARK | 351 | Q96PY6 | |
| RKISEEAARKRRLEF | 356 | Q96PY6 | |
| KRSFDVREVIARIVD | 326 | Q9HCC0 | |
| KKDEERRESRIQSYS | 621 | O95835 | |
| ARKTETRVEEAFRHK | 1101 | Q9ULI0 | |
| VRSSVEAERKKLQRE | 446 | Q9ULE4 | |
| ESEDDEIFRRKVKRA | 1416 | Q8IYD8 | |
| KRKLSFRRRTDKDTE | 886 | Q12809 | |
| VTAEFKETRRRLSVE | 336 | O95069 | |
| VFVETKRRCDELTRK | 346 | P17844 | |
| TFEEGRRLKEEAQKR | 496 | Q9UL16 | |
| REKAVRVDKLESEVS | 316 | Q3V6T2 | |
| RVDKLESEVSRYKER | 321 | Q3V6T2 | |
| ERAVREVDFTKKRLQ | 1376 | Q92614 | |
| ISFKSFFRRRKTDEE | 926 | Q9H792 | |
| LKRREEEKVSAVSAE | 646 | Q99081 | |
| ERESAIERERFSKEV | 481 | Q6KC79 | |
| RDRDVDKRDSSVSKD | 826 | Q8WXX7 | |
| VFRKISDVKREEEER | 706 | O95259 | |
| RKELERKREESQSEI | 1031 | Q13136 | |
| EKRVKDTESELFRTK | 186 | Q86VQ0 | |
| SIASSVRRKDERRKE | 316 | Q8N9T8 | |
| QSRTDDKVIRFKRAI | 311 | Q9NZB2 | |
| SKRSLRKVDVEEEFF | 1511 | P46013 | |
| RKVDVEEEFFALRKR | 1516 | P46013 | |
| KIFRKSRISEEDDRS | 266 | Q13316 | |
| RVSEEKEVTEERLKA | 111 | Q86T90 | |
| EFSFEKARVRKDSSE | 141 | Q13237 | |
| RVADERDRVQKKTFT | 71 | Q9UPN3 | |
| IAEEKAREAESKART | 301 | Q9Y6X9 | |
| EDITLESERKRIFKD | 781 | O75400 | |
| SSKKRVRQLREEFDR | 436 | O43182 | |
| EDDDKRRALRTASEK | 531 | Q08828 | |
| EQVKETVERIFRRSK | 501 | Q8N4S0 | |
| FRAIKVDRRSSDDEV | 426 | Q8IV32 | |
| SKFRRKASEEIEDFR | 71 | Q96FT9 | |
| TRKFRDAEQEKDRTL | 491 | Q9P2K1 | |
| SEKAVEEAVKRTRDE | 381 | Q7Z6B0 | |
| KKSEAVRRLVEAAEE | 101 | Q8IZS8 | |
| RSEIERLTAKIEEFR | 136 | Q96MT8 | |
| YSRKEEAIRKIESER | 1871 | P15924 | |
| EAIRKIESEREKSER | 1876 | P15924 | |
| FKDTRTQEDKRRDVD | 741 | Q9HC77 | |
| EDFRTDRAVRITKKE | 571 | Q3T8J9 | |
| DFDRAAEDVRKLKAR | 6 | Q8N6N7 | |
| RVDRTVKEAEEKLTE | 2576 | Q12955 | |
| ATEKRESERRQVEEK | 216 | O14645 | |
| KAEIDRRISAFIERK | 156 | Q9NS73 | |
| ARKELETLRERFSES | 436 | O95466 | |
| RDFFKTRSKEEIAEI | 766 | Q8N7U6 | |
| FTLEKRVKLEERSRD | 226 | Q12912 | |
| TDARRVELKKRVDDY | 451 | Q15051 | |
| DTEAKIRRITDLERK | 1706 | A4D0S4 | |
| IRSEEEKVRFERQKA | 741 | Q5FWF5 | |
| RAAVIERFREGKEKV | 371 | Q9NUU7 | |
| KVKREEVDRRVLETE | 391 | P34947 | |
| VRAETRSRAKDDIKR | 6 | Q4VC05 | |
| KVKLSSERERVEDLF | 6 | P49336 | |
| EDEVKAARTRRKVLS | 26 | Q15020 | |
| EESEKAAESRIKRLR | 916 | Q9UPN4 | |
| LEKSRAVRQAKDERT | 266 | P35580 | |
| KRLRFDKEGEVRETA | 246 | Q9NY27 | |
| KRRKRTIADESAENV | 1196 | Q2WGJ9 | |
| VAKARLEETDRRTAK | 191 | P47897 | |
| KETIEKIFESRFEKR | 386 | O75691 | |
| VLSEDRKSVKFVETR | 351 | Q9HCM9 | |
| FRTEKERERQAKLAE | 116 | P13805 | |
| TFLKDRTKFEEKVRE | 46 | Q17RP2 | |
| SRSSEEREVKEKRTF | 451 | Q93075 | |
| FVIKERDTLKERERE | 1191 | Q8WXH0 | |
| ERAATFEHDRDKVKR | 156 | Q7Z494 | |
| REFRAKTNRDLEIKD | 476 | Q86SQ7 | |
| RIRTTKDEEFIRKFA | 1196 | P21675 | |
| EAREIFKDAERTKLF | 86 | P08709 | |
| RKLSEKDEEIENFRR | 1586 | Q9Y2K3 | |
| IKKRFVSEAELDERR | 11 | Q9GZU8 | |
| ERSERAFKLTRDAIE | 111 | P49354 | |
| GRFEEDFIEKRKRRL | 296 | Q8WV41 | |
| ADVSEEERSRKRKLD | 601 | Q9UBT2 | |
| EEIEAERATRAKTEK | 1121 | P11055 | |
| EKRRGKRVRFAEDEE | 301 | Q5C9Z4 | |
| IEFSTEVKAVKLRRD | 96 | Q5MNZ6 | |
| REREKRDKARESENS | 21 | Q9P2R6 | |
| ETLRKVRDEFVIRDE | 21 | Q06520 | |
| KIDEEVRRFRETRQK | 496 | P49959 | |
| KLSFQESDRKEREER | 151 | Q9H930 | |
| DKLEKTRRESQSERE | 741 | Q5VT25 | |
| SREKRSVVSFDKVKE | 596 | Q15424 | |
| ISFEEFERRREERKT | 16 | Q9Y5Q9 | |
| RRRGETESEEFEKLK | 541 | Q05682 | |
| KESTRIAEAIRDFVK | 326 | Q8N8U2 | |
| RVKREDFEARKAAIE | 56 | Q6V702 | |
| ERRKRESKILASFRE | 376 | Q5M9Q1 | |
| VKLKVDSFRERITSE | 11 | P61289 | |
| RKSKRRNSEFEIFVD | 51 | P17752 | |
| AVDRSVKRLFKVRSD | 331 | Q9H900 | |
| RIENREKSLDKTERV | 406 | A4D1E1 | |
| RLEEFRSDSAKEEVR | 86 | Q5JTV8 | |
| TRAEFAERTVAKLEK | 201 | P67936 | |
| DRKRREAAERSKEAA | 51 | Q8N443 | |
| VDLEKLEARKRRFAD | 976 | Q96T58 | |
| YDETEAEREKKRLER | 181 | Q8NEJ9 | |
| DKDKERSRDERERST | 381 | Q05519 | |
| DRFSEEFVETRRKAL | 166 | Q5VWJ9 | |
| KEVAKRLSRDQRFRE | 471 | A6NEE1 | |
| SQFTRTKEELEAEKR | 111 | P12270 | |
| SEEEEKETRGVQKRR | 276 | Q92504 | |
| QRRVSEKEKESIARA | 121 | Q86Y82 | |
| FIFKDEERTRVKLES | 181 | Q92519 | |
| VERSRKTLEAREKEE | 51 | Q9NW82 | |
| KEEKESSREKRERSR | 156 | Q8IYB3 | |
| RKFTKRDVFLERGEV | 546 | P24928 | |
| RDKSRESLEEAAKRQ | 76 | Q9NQB0 | |
| DRVRKSESEDSIRRK | 521 | Q99250 | |
| EFEEERSREEKRSIK | 471 | Q9H5I5 | |
| DQARKRLTKRSEEVV | 91 | O14907 | |
| ERTKEELARSEARRK | 861 | Q9UKX3 | |
| DRTELDRKEKLTFTE | 186 | Q8IYM2 | |
| DEVAREFVKLKSESR | 1571 | O14795 | |
| TRRFKETNDKAELDR | 516 | Q13123 | |
| REKREKVSLFERVTG | 351 | Q7L804 | |
| ILSFDKIKEQRERER | 611 | Q14151 | |
| SIEEFRAKIERARSD | 701 | Q15149 | |
| IRAEVEKARRKAESD | 236 | Q9H6N6 | |
| KRKEDTVVATLRVFD | 286 | P07949 | |
| IASEEKSRAAERKRI | 311 | Q9Y2K1 | |
| IKKFRDEARRLEESD | 81 | O43615 | |
| EKDAVSREIRLKRFL | 1176 | Q14669 | |
| RAERAARFAKTKEEV | 276 | Q92575 | |
| DTDDRHRIEEKRKRT | 291 | Q04206 | |
| RASVKEFKEEISRRF | 31 | Q9NRR5 | |
| KRKRRLEDAFIVISD | 31 | Q96RL1 | |
| TREFRTRKKLEEERH | 96 | Q15637 | |
| QRAREEEEKRKEVTS | 261 | P40222 | |
| RKSLEREDFEKTIAE | 106 | Q02108 | |
| EQSETATKRRILKER | 681 | P20592 |